| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 1.72e-06 | 4 | 152 | 3 | GO:0004971 | |
| GeneOntologyMolecularFunction | cadherin binding | FLNA FLNB PUF60 ANXA1 TWF2 TJP1 WASF2 NUMB CLINT1 SCRIB PCBP1 CDH1 | 1.15e-05 | 339 | 152 | 12 | GO:0045296 |
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 5.76e-05 | 2 | 152 | 2 | GO:0005093 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNA FLNB PUF60 ANXA1 TWF2 ADAM10 NRXN3 TJP1 WASF2 NUMB CLINT1 SCRIB PCBP1 CDH1 | 2.00e-04 | 599 | 152 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNA FLNB MYH3 MYH6 MAP1B CENPF GBP2 GRIA1 TWF2 SPAG9 DYSF EML3 OPA1 SPTBN4 NKD2 PPP5C WASF2 RP1 BRSK1 CDH1 | 2.60e-04 | 1099 | 152 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.72e-04 | 17 | 152 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.24e-04 | 18 | 152 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | double-stranded DNA helicase activity | 3.42e-04 | 4 | 152 | 2 | GO:0036121 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 5.67e-04 | 5 | 152 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | ZXDC COL11A1 TCF20 BCLAF1 PDZK1 PEX6 E2F1 SPAG9 ACSS2 PARP14 TRIM24 ADAM10 AR SPTBN4 NCOR1 SHANK2 NKD2 COL14A1 SCRIB FHL2 CDH1 NUP153 | 6.12e-04 | 1356 | 152 | 22 | GO:0060090 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 7.78e-04 | 24 | 152 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | cyclosporin A binding | 7.78e-04 | 24 | 152 | 3 | GO:0016018 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.11e-03 | 27 | 152 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.23e-03 | 28 | 152 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 5.51e-06 | 269 | 153 | 11 | GO:0002064 | |
| GeneOntologyBiologicalProcess | keratinocyte development | 6.43e-06 | 17 | 153 | 4 | GO:0003334 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 FLNA FLNB MAP1B MYCBP2 ANXA1 TWF2 FRYL SPAG9 ADAM10 GDI1 AR OPA1 SYNGAP1 SPTBN4 LIF NRXN3 WASF2 NUMB SCRIB CFAP70 IHH BRSK1 CDH1 | 7.81e-06 | 1194 | 153 | 24 | GO:0000902 |
| GeneOntologyBiologicalProcess | tube development | GPLD1 CLDN18 FLNA RBM15 FAT4 AIMP1 ABCA12 ANXA1 VPS4B MUC19 TSC1 TEK DYSF AR OPA1 LIF NRXN3 TJP1 SCG2 WASF2 KCTD10 NUMB SCRIB IHH CSMD1 CDH1 | 1.30e-05 | 1402 | 153 | 26 | GO:0035295 |
| GeneOntologyBiologicalProcess | tube morphogenesis | GPLD1 FLNA RBM15 FAT4 AIMP1 ANXA1 VPS4B TSC1 TEK DYSF AR OPA1 LIF NRXN3 TJP1 SCG2 WASF2 KCTD10 SCRIB IHH CSMD1 CDH1 | 2.97e-05 | 1125 | 153 | 22 | GO:0035239 |
| GeneOntologyBiologicalProcess | epithelial cell morphogenesis | 3.08e-05 | 49 | 153 | 5 | GO:0003382 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | GPLD1 FLNA MYH3 RBM15 MYH6 AIMP1 ANXA1 VPS4B UNC13D TSC1 RDH13 TEK DYSF AR OPA1 LIF NRXN3 TJP1 SCG2 WASF2 KCTD10 ERVK-19 SCRIB IHH FHL2 CDH1 | 3.42e-05 | 1483 | 153 | 26 | GO:0048646 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FLNA RBM15 MYH6 FAT4 COL11A1 TSC1 TEK AR OPA1 LIF NUMB SCRIB IHH CSMD1 BRSK1 KDF1 CDH1 | 4.32e-05 | 750 | 153 | 17 | GO:0048729 |
| GeneOntologyBiologicalProcess | corneocyte desquamation | 5.47e-05 | 2 | 153 | 2 | GO:0003336 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | FLNA RBM15 FAT4 TSC1 TEK AR OPA1 LIF NUMB SCRIB IHH CSMD1 BRSK1 KDF1 CDH1 | 5.93e-05 | 619 | 153 | 15 | GO:0002009 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | MAP1B CENPF TWF2 DYSF GDI2 OPA1 PPIF SPTBN4 LIF TJP1 WASF2 RP1 | 7.40e-05 | 421 | 153 | 12 | GO:0010639 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | FLNA MAP1B CENPF TWF2 TSC1 DYSF GDI1 GDI2 AR OPA1 PPIF SYNGAP1 SPTBN4 LIF TJP1 WASF2 RP1 CDH1 | 7.56e-05 | 864 | 153 | 18 | GO:0051129 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | FLNA ABCA12 PDZK1 ADAM10 AR EFR3A SPTBN4 NRXN3 NKD2 NUMB SCRIB CDH1 | 7.57e-05 | 422 | 153 | 12 | GO:1990778 |
| GeneOntologyBiologicalProcess | epithelium development | ZNF703 FLNA FLNB RBM15 FAT4 CDSN MAP1B ABCA12 ANXA1 TRPS1 TSC1 TEK AR OPA1 LIF NCOR1 TJP1 NUMB ROS1 SCRIB IHH CSMD1 BRSK1 KDF1 CDH1 | 7.98e-05 | 1469 | 153 | 25 | GO:0060429 |
| GeneOntologyBiologicalProcess | adherens junction organization | 8.95e-05 | 61 | 153 | 5 | GO:0034332 | |
| GeneOntologyBiologicalProcess | cell junction organization | CLDN18 ZNF703 FLNA MAP1B MYCBP2 GRIA1 TSC1 TEK ADAM10 OPA1 SYNGAP1 SPTBN4 NRXN3 SHANK2 TJP1 WASF2 NUMB C1QC CDH1 | 1.12e-04 | 974 | 153 | 19 | GO:0034330 |
| GeneOntologyBiologicalProcess | developmental growth | CLDN18 MYH6 MAP1B MYCBP2 SGCA ANXA1 TWF2 SPAG9 TEC DYSF GDI1 AR SPTBN4 NCOR1 COL14A1 IHH KDF1 CDH1 | 1.47e-04 | 911 | 153 | 18 | GO:0048589 |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | 1.58e-04 | 324 | 153 | 10 | GO:0072659 | |
| GeneOntologyBiologicalProcess | synapse organization | FLNA MAP1B MYCBP2 GRIA1 TSC1 ADAM10 OPA1 SYNGAP1 SPTBN4 NRXN3 SHANK2 WASF2 NUMB C1QC CDH1 | 1.81e-04 | 685 | 153 | 15 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | FLNA MAP1B MYCBP2 TWF2 TSC1 ADAM10 GDI1 GDI2 OPA1 SYNGAP1 LIF TRIM67 WASF2 NUMB RP1 BRSK1 CDH1 | 1.86e-04 | 846 | 153 | 17 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | FLNA MAP1B MYCBP2 TWF2 TSC1 ADAM10 GDI1 OPA1 SYNGAP1 LIF TRIM67 NUMB BRSK1 CDH1 | 1.92e-04 | 612 | 153 | 14 | GO:0010975 |
| GeneOntologyBiologicalProcess | neuron development | CHL1 FLNA FAT4 MAP1B MYCBP2 TWF2 TSC1 FRYL SPAG9 RDH13 ADAM10 GDI1 OPA1 SYNGAP1 SPTBN4 LIF NRXN3 TRIM67 NUMB RP1 SCRIB IHH BRSK1 CDH1 | 1.97e-04 | 1463 | 153 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | maternal process involved in female pregnancy | 2.11e-04 | 73 | 153 | 5 | GO:0060135 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | FLNA MAP1B MYCBP2 TWF2 TSC1 ADAM10 GDI1 GDI2 OPA1 SYNGAP1 LIF TRIM67 WASF2 NUMB RP1 BRSK1 CDH1 | 2.35e-04 | 863 | 153 | 17 | GO:0031344 |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 2.38e-04 | 41 | 153 | 4 | GO:0061436 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | FLNA ABCA12 PDZK1 SRP68 ADAM10 GDI1 AR EFR3A SYNGAP1 SPTBN4 NRXN3 NKD2 NUMB SCRIB CDH1 | 2.47e-04 | 705 | 153 | 15 | GO:0072657 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | ZNF703 FLNA FLNB FAT4 CDSN MAP1B ABCA12 ANXA1 AR LIF TJP1 NUMB ROS1 SCRIB IHH KDF1 CDH1 | 2.58e-04 | 870 | 153 | 17 | GO:0030855 |
| GeneOntologyBiologicalProcess | angiogenesis | GPLD1 FLNA RBM15 AIMP1 ANXA1 VPS4B TEK DYSF LIF NRXN3 TJP1 SCG2 WASF2 KCTD10 IHH | 2.58e-04 | 708 | 153 | 15 | GO:0001525 |
| GeneOntologyBiologicalProcess | regulation of developmental growth | MYH6 MAP1B MYCBP2 TWF2 SPAG9 GDI1 AR SPTBN4 NCOR1 COL14A1 CDH1 | 3.14e-04 | 421 | 153 | 11 | GO:0048638 |
| GeneOntologyBiologicalProcess | corneocyte development | 3.25e-04 | 4 | 153 | 2 | GO:0003335 | |
| GeneOntologyBiologicalProcess | circulatory system development | GPLD1 FLNA RBM15 MYH6 FAT4 COL11A1 AIMP1 DYNC2H1 ANXA1 VPS4B TSC1 TEK DYSF ADAM10 LIF NRXN3 TJP1 SCG2 WASF2 KCTD10 COL14A1 IHH FHL2 | 4.04e-04 | 1442 | 153 | 23 | GO:0072359 |
| GeneOntologyCellularComponent | anchoring junction | CLDN18 FLNA FLNB CDSN SGCA ANXA1 RPS11 SRP68 GRIA1 TEC TEK ADAM10 GDI2 SPTBN4 TJP1 WASF2 NUMB SCRIB FHL2 KDF1 CDH1 VAV1 | 2.33e-06 | 976 | 152 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | CLDN18 FLNA CDSN SGCA ANXA1 GRIA1 TEC TEK ADAM10 SPTBN4 TJP1 WASF2 SCRIB CDH1 VAV1 | 2.79e-05 | 591 | 152 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | supramolecular fiber | FLNA FLNB MYH3 MYH6 MTMR12 COL11A1 MAP1B DYNC2H1 ANXA1 DNAH2 TWF2 TSC1 CMYA5 TEK DYSF EML3 OPA1 SPTBN4 DNAH12 SHANK2 RP1 FHL2 | 4.43e-05 | 1179 | 152 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | FLNA FLNB MYH3 MYH6 MTMR12 COL11A1 MAP1B DYNC2H1 ANXA1 DNAH2 TWF2 TSC1 CMYA5 TEK DYSF EML3 OPA1 SPTBN4 DNAH12 SHANK2 RP1 FHL2 | 4.90e-05 | 1187 | 152 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | FLNA RANBP2 GALNT3 MAP1B CENPF GBP2 TWF2 TSC1 SPAG9 CMYA5 AKIP1 TEK ADAM10 NCOR1 UBR5 IGHMBP2 ROS1 CLINT1 CDH1 | 4.95e-05 | 934 | 152 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | axon | FLNA MAP1B MYCBP2 PRSS12 GRIA1 GRIA3 GRIA4 TWF2 TSC1 ADAM10 GDI1 AR OPA1 SPTBN4 SHANK2 IGHMBP2 BRSK1 CDH1 | 8.65e-05 | 891 | 152 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNA FLNB MYH3 MYH6 ANXA1 GBP2 TWF2 TSC1 TEK SPTBN4 TJP1 WASF2 CDH1 | 3.07e-04 | 576 | 152 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | distal axon | FLNA MAP1B PRSS12 GRIA3 GRIA4 TWF2 TSC1 SHANK2 IGHMBP2 BRSK1 CDH1 | 3.50e-04 | 435 | 152 | 11 | GO:0150034 |
| GeneOntologyCellularComponent | postsynaptic density | MAP1B GRIA1 GRIA3 GRIA4 TSC1 ADAM10 SYNGAP1 SHANK2 NUMB SCRIB PCBP1 | 4.73e-04 | 451 | 152 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 5.71e-04 | 320 | 152 | 9 | GO:0016323 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.86e-04 | 141 | 152 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | dynein complex | 6.41e-04 | 54 | 152 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | actin filament | 7.04e-04 | 146 | 152 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | asymmetric synapse | MAP1B GRIA1 GRIA3 GRIA4 TSC1 ADAM10 SYNGAP1 SHANK2 NUMB SCRIB PCBP1 | 7.52e-04 | 477 | 152 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | axonemal dynein complex | 7.71e-04 | 25 | 152 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | axoneme | 8.13e-04 | 207 | 152 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 8.36e-04 | 208 | 152 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | myofibril | 8.87e-04 | 273 | 152 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | glutamatergic synapse | FLNA MAP1B PRSS12 GRIA1 GRIA3 GRIA4 ADAM10 EFR3A SYNGAP1 NRXN3 SHANK2 NUMB C1QC SCRIB CDH1 | 9.25e-04 | 817 | 152 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP1B GRIA1 GRIA3 GRIA4 TSC1 ADAM10 SYNGAP1 SHANK2 NUMB SCRIB PCBP1 | 1.16e-03 | 503 | 152 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | basal plasma membrane | 1.16e-03 | 354 | 152 | 9 | GO:0009925 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.17e-03 | 161 | 152 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | focal adhesion | 1.25e-03 | 431 | 152 | 10 | GO:0005925 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.30e-03 | 290 | 152 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 1.32e-03 | 30 | 152 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | apical part of cell | CHL1 FAT4 DYNC2H1 ANXA1 PDZK1 TEK SHANK2 TJP1 NUMB CD300LG SCRIB CDH1 | 1.33e-03 | 592 | 152 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | cell-substrate junction | 1.53e-03 | 443 | 152 | 10 | GO:0030055 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP1B GRIA1 GRIA3 GRIA4 TSC1 ADAM10 SYNGAP1 SHANK2 NUMB SCRIB PCBP1 | 1.58e-03 | 523 | 152 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | basal part of cell | 1.83e-03 | 378 | 152 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | dendritic spine | 2.00e-03 | 242 | 152 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | presynapse | WDR7 PRSS12 RPS11 GRIA1 GRIA3 GRIA4 DYSF ADAM10 GDI1 NRXN3 SHANK2 C1QC SCRIB BRSK1 CDH1 | 2.05e-03 | 886 | 152 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | dendritic shaft | 2.08e-03 | 74 | 152 | 4 | GO:0043198 | |
| GeneOntologyCellularComponent | neuron spine | 2.24e-03 | 247 | 152 | 7 | GO:0044309 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.27e-03 | 10 | 152 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 2.28e-03 | 317 | 152 | 8 | GO:0032838 | |
| GeneOntologyCellularComponent | sarcomere | 2.34e-03 | 249 | 152 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | FLNA MAP1B DYNC2H1 ANXA1 DNAH2 TWF2 TSC1 TEK DYSF EML3 OPA1 SPTBN4 DNAH12 SHANK2 RP1 | 2.36e-03 | 899 | 152 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.53e-03 | 78 | 152 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.56e-03 | 253 | 152 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CHL1 FLNA FLNB MAP1B PRSS12 GRIA1 GRIA3 GRIA4 ADAM10 GDI1 AR OPA1 SYNGAP1 SPTBN4 SHANK2 PPP5C IGHMBP2 NUMB | 3.58e-03 | 1228 | 152 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | CHL1 FLNA MAP1B PRSS12 GRIA1 GRIA3 GRIA4 ADAM10 AR OPA1 SYNGAP1 SHANK2 PPP5C NUMB | 4.01e-03 | 858 | 152 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CHL1 FLNA MAP1B PRSS12 GRIA1 GRIA3 GRIA4 ADAM10 AR OPA1 SYNGAP1 SHANK2 PPP5C NUMB | 4.09e-03 | 860 | 152 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | lateral plasma membrane | 4.23e-03 | 90 | 152 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 4.28e-03 | 45 | 152 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | annulate lamellae | 4.51e-03 | 14 | 152 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | adherens junction | 4.62e-03 | 212 | 152 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | cytoplasmic region | 4.91e-03 | 360 | 152 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | host cellular component | 5.18e-03 | 15 | 152 | 2 | GO:0018995 | |
| HumanPheno | Abnormal shoulder morphology | FLNA FLNB MYH3 MAP1B SGCA PUF60 TRPS1 AK9 DYSF OPA1 SPRTN PLOD1 | 8.45e-06 | 246 | 55 | 12 | HP:0003043 |
| HumanPheno | Short femur | 1.67e-05 | 31 | 55 | 5 | HP:0003097 | |
| Domain | AAA | 2.15e-05 | 144 | 150 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 2.15e-05 | 144 | 150 | 8 | IPR003593 | |
| Domain | RabGDI | 6.41e-05 | 2 | 150 | 2 | IPR000806 | |
| Domain | Filamin | 7.99e-05 | 11 | 150 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 7.99e-05 | 11 | 150 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 7.99e-05 | 11 | 150 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 7.99e-05 | 11 | 150 | 3 | IPR017868 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.73e-04 | 14 | 150 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 1.73e-04 | 14 | 150 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.73e-04 | 14 | 150 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.73e-04 | 14 | 150 | 3 | IPR011704 | |
| Domain | AAA_8 | 1.73e-04 | 14 | 150 | 3 | PF12780 | |
| Domain | AAA_5 | 1.73e-04 | 14 | 150 | 3 | PF07728 | |
| Domain | DHC_fam | 2.15e-04 | 15 | 150 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.15e-04 | 15 | 150 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.15e-04 | 15 | 150 | 3 | IPR004273 | |
| Domain | fn3 | 3.38e-04 | 162 | 150 | 7 | PF00041 | |
| Domain | Lig_chan-Glu_bd | 3.79e-04 | 18 | 150 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 3.79e-04 | 18 | 150 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 3.79e-04 | 18 | 150 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 3.79e-04 | 18 | 150 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 3.79e-04 | 18 | 150 | 3 | IPR001508 | |
| Domain | Lig_chan | 3.79e-04 | 18 | 150 | 3 | PF00060 | |
| Domain | PBPe | 3.79e-04 | 18 | 150 | 3 | SM00079 | |
| Domain | GDI | 3.80e-04 | 4 | 150 | 2 | PF00996 | |
| Domain | GDP_dissociation_inhibitor | 3.80e-04 | 4 | 150 | 2 | IPR018203 | |
| Domain | Cyclophilin-type_PPIase_CS | 4.48e-04 | 19 | 150 | 3 | IPR020892 | |
| Domain | PolyA | 6.31e-04 | 5 | 150 | 2 | SM00517 | |
| Domain | - | 6.31e-04 | 5 | 150 | 2 | 1.10.1900.10 | |
| Domain | PABP | 6.31e-04 | 5 | 150 | 2 | PF00658 | |
| Domain | Cyt_P450_E_grp-II | 6.31e-04 | 5 | 150 | 2 | IPR002402 | |
| Domain | PABC | 6.31e-04 | 5 | 150 | 2 | PS51309 | |
| Domain | PABP_HYD | 6.31e-04 | 5 | 150 | 2 | IPR002004 | |
| Domain | Pro_isomerase | 6.99e-04 | 22 | 150 | 3 | PF00160 | |
| Domain | Cyclophilin-type_PPIase_dom | 6.99e-04 | 22 | 150 | 3 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 6.99e-04 | 22 | 150 | 3 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 6.99e-04 | 22 | 150 | 3 | PS50072 | |
| Domain | - | 6.99e-04 | 22 | 150 | 3 | 2.40.100.10 | |
| Domain | CSA_PPIASE_1 | 6.99e-04 | 22 | 150 | 3 | PS00170 | |
| Domain | FN3 | 7.47e-04 | 185 | 150 | 7 | SM00060 | |
| Domain | ACTININ_2 | 7.99e-04 | 23 | 150 | 3 | PS00020 | |
| Domain | ACTININ_1 | 7.99e-04 | 23 | 150 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.99e-04 | 23 | 150 | 3 | IPR001589 | |
| Domain | Cyt_P450_E_CYP3A | 9.41e-04 | 6 | 150 | 2 | IPR008072 | |
| Domain | FN3 | 1.14e-03 | 199 | 150 | 7 | PS50853 | |
| Domain | Laminin_G | 1.21e-03 | 58 | 150 | 4 | IPR001791 | |
| Domain | P-loop_NTPase | MYH3 MYH6 ABCA12 DYNC2H1 VPS4B DNAH2 PEX6 GBP2 AK9 OPA1 LRGUK DNAH12 SBNO1 TJP1 IGHMBP2 GNL2 | 1.32e-03 | 848 | 150 | 16 | IPR027417 |
| Domain | FN3_dom | 1.52e-03 | 209 | 150 | 7 | IPR003961 | |
| Domain | Ig-like_fold | CHL1 FLNA FLNB MYCBP2 SGCA CMYA5 TEK PKHD1L1 IGSF22 TRIM67 SHANK2 CD300LG COL14A1 ROS1 | 1.68e-03 | 706 | 150 | 14 | IPR013783 |
| Domain | DHC_N1 | 1.74e-03 | 8 | 150 | 2 | PF08385 | |
| Domain | Helicase/UvrB_N | 1.74e-03 | 8 | 150 | 2 | IPR006935 | |
| Domain | ResIII | 1.74e-03 | 8 | 150 | 2 | PF04851 | |
| Domain | Dynein_heavy_dom-1 | 1.74e-03 | 8 | 150 | 2 | IPR013594 | |
| Domain | CH | 1.85e-03 | 65 | 150 | 4 | SM00033 | |
| Domain | ConA-like_dom | 1.98e-03 | 219 | 150 | 7 | IPR013320 | |
| Domain | CH | 2.43e-03 | 70 | 150 | 4 | PF00307 | |
| Pubmed | FLNA FLNB RANBP2 RBM15 TCF20 MAP1B MYCBP2 CENPF PUF60 ANXA1 PABPC4 GART SRP68 FRYL SPAG9 ZNF318 GDI1 GDI2 WDR3 UBR5 TJP1 GNL2 PLOD1 NUP153 | 2.58e-15 | 653 | 156 | 24 | 22586326 | |
| Pubmed | RANBP2 TCF20 MYCBP2 CENPF WDR7 BCLAF1 GRIA1 GRIA3 GRIA4 TSC1 ZNF318 GDI1 GDI2 OPA1 SYNGAP1 SPTBN4 NCOR1 TRIM67 SHANK2 UBR5 TJP1 WASF2 SCRIB FRMPD3 BRSK1 PCBP1 NUP153 | 2.84e-14 | 963 | 156 | 27 | 28671696 | |
| Pubmed | ZNF703 FLNA RANBP2 DCAF8 AIMP1 PUF60 BCLAF1 PABPC4 GART TRPS1 RPS11 SRP68 OPA1 UBR5 TRIM56 GNL2 FHL2 PCBP1 PLOD1 NUP153 | 1.83e-11 | 655 | 156 | 20 | 35819319 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA FLNB RANBP2 RBM15 TCF20 MAP1B MYCBP2 CENPF PUF60 ANXA1 BCLAF1 PABPC4 GART RPS11 ZNF318 WDR3 UBR5 TJP1 GNL2 SCRIB MMAB PCBP1 PLOD1 NUP153 | 3.71e-11 | 1024 | 156 | 24 | 24711643 |
| Pubmed | FLNA FLNB MYH6 IGHV3-15 MAP1B WDR7 ANXA1 BCLAF1 PABPC4 RPS11 SRP68 GRIA1 TWF2 TSC1 SUCLG1 GDI1 GDI2 OPA1 SYNGAP1 SPTBN4 SHANK2 TJP1 KCTD10 MRPL48 C1QC SCRIB BRSK1 PCBP1 | 4.86e-11 | 1431 | 156 | 28 | 37142655 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHX1 FLNA FLNB RANBP2 CDSN MAP1B AIMP1 PUF60 ANXA1 BCLAF1 GART RPS11 SRP68 TWF2 FRYL SUCLG1 GDI1 GDI2 OPA1 PPIF PPP5C TJP1 NUMB SCRIB FHL2 PCBP1 PLOD1 | 9.18e-11 | 1367 | 156 | 27 | 32687490 |
| Pubmed | FLNA TCF20 MAP1B MYCBP2 PUF60 BCLAF1 SRP68 TWF2 SPAG9 ZNF318 NCOR1 TJP1 NUMB RPRD2 CLINT1 SCRIB PCBP1 | 5.31e-10 | 549 | 156 | 17 | 38280479 | |
| Pubmed | FLNA FLNB RANBP2 SPNS1 TCF20 MYCBP2 CENPF AIMP1 VPS4B TRPS1 RPS11 ZNF318 TRIM24 NCOR1 UBR5 | 7.93e-10 | 418 | 156 | 15 | 34709266 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA RANBP2 MAP1B PUF60 BCLAF1 GART RPS11 SRP68 TSC1 SPAG9 ZNF318 TJP1 WASF2 FAM169A GNL2 NUMB RPRD2 CLINT1 SCRIB PCBP1 NUP153 | 1.46e-09 | 934 | 156 | 21 | 33916271 |
| Pubmed | FLNA FLNB MYH3 RANBP2 MYH6 MAP1B CENPF BCLAF1 PABPC4 RPS11 DNAH2 GRIA1 GRIA3 GRIA4 TSC1 ZNF318 SPTBN4 NCOR1 NRXN3 TRIM67 SHANK2 SBNO1 TJP1 FAM169A TMPRSS7 CDH1 | 1.47e-09 | 1442 | 156 | 26 | 35575683 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNA FLNB RANBP2 DCAF8 MAP1B MYCBP2 AIMP1 PUF60 ANXA1 PABPC4 GART RPS11 SRP68 SPAG9 ME1 GDI1 GDI2 PPP5C UBR5 WASF2 PPIH PCBP1 NUP153 | 2.07e-09 | 1149 | 156 | 23 | 35446349 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNA FLNB RBM15 CENPF AIMP1 PUF60 ANXA1 BCLAF1 PABPC4 GART RPS11 SRP68 GDI1 WDR3 TJP1 TRIM56 KCTD10 GNL2 CLINT1 SCRIB FHL2 PCBP1 CDH1 NUP153 | 2.24e-09 | 1257 | 156 | 24 | 36526897 |
| Pubmed | EPHX1 FLNB RANBP2 MAP1B BCLAF1 PABPC4 GART RPS11 SRP68 CACHD1 OPA1 EFR3A WASF2 NUMB CLINT1 SCRIB PCBP1 NUP153 | 3.60e-09 | 708 | 156 | 18 | 39231216 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPHX1 FLNA FLNB RANBP2 RBM15 CDSN CENPF AIMP1 DYNC2H1 PUF60 BCLAF1 PABPC4 GART RPS11 SRP68 CMYA5 GDI2 OPA1 WDR3 PPP5C SBNO1 GNL2 CLINT1 PCBP1 NUP153 | 5.46e-09 | 1425 | 156 | 25 | 30948266 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FLNA FLNB DCAF8 AIMP1 PUF60 PABPC4 GART RPS11 GBP2 SRP68 UNC13D TWF2 FRYL SPAG9 CMYA5 ME1 GDI1 GDI2 PPP5C SBNO1 WASF2 CLINT1 FHL2 PCBP1 PLOD1 | 8.26e-09 | 1455 | 156 | 25 | 22863883 |
| Pubmed | FLNA RANBP2 RBM15 PUF60 BCLAF1 VPS4B PABPC4 GART RPS11 SRP68 SUCLG1 ME1 GDI1 GDI2 OPA1 NCOR1 PPP5C TJP1 WASF2 IGHMBP2 FHL2 PCBP1 CDH1 | 9.55e-09 | 1247 | 156 | 23 | 27684187 | |
| Pubmed | ZNF703 RANBP2 RBM15 MTMR12 MYCBP2 TRPS1 TSC1 SPAG9 CACHD1 ME1 OPA1 EFR3A NCOR1 PPP5C TJP1 GNL2 NUMB CLINT1 SCRIB PLOD1 NUP153 | 1.11e-08 | 1049 | 156 | 21 | 27880917 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | FLNA RANBP2 CDSN MAP1B ANXA1 SPAG9 ZNF318 EYA3 TRIM24 NCOR1 SBNO1 TJP1 CLINT1 PCBP1 | 1.53e-08 | 444 | 156 | 14 | 34795231 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | FLNA FLNB RANBP2 CENPF RPS11 SRP68 ZNF318 EFR3A TJP1 CLINT1 SCRIB | 2.52e-08 | 256 | 156 | 11 | 33397691 |
| Pubmed | FLNA RANBP2 RBM15 TCF20 MYCBP2 PUF60 ANXA1 BCLAF1 PABPC4 SRP68 TWF2 ZNF318 EYA3 TRIM24 GDI2 NCOR1 PPP5C UBR5 CLINT1 PPIH NUP153 | 2.62e-08 | 1103 | 156 | 21 | 34189442 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FLNA FLNB PUF60 ANXA1 TWF2 EFR3A SHANK2 TJP1 WASF2 NUMB CLINT1 SCRIB PCBP1 KDF1 CDH1 | 4.43e-08 | 565 | 156 | 15 | 25468996 |
| Pubmed | EPHX1 FLNA RBM15 FAT4 COL11A1 WDR7 DYNC2H1 GART DNAH2 GBP2 SRP68 TRIM24 GDI2 UBR5 ROS1 PPIH PLOD1 | 5.72e-08 | 754 | 156 | 17 | 35906200 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | RBM15 CENPF TSC1 AK9 DYSF ME1 OPA1 NSUN7 SYNGAP1 DNAH12 IGHMBP2 GNL2 RP1 PLOD1 | 6.18e-08 | 497 | 156 | 14 | 36774506 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | FLNA RANBP2 RBM15 TCF20 MAP1B PUF60 BCLAF1 PABPC4 ZNF318 TRIM24 WDR3 NCOR1 C5orf24 TJP1 GNL2 RPRD2 CLINT1 PCBP1 NUP153 | 6.35e-08 | 954 | 156 | 19 | 36373674 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | FLNA RANBP2 GART ZNF318 TRIM24 NCOR1 NKD2 UBR5 SBNO1 RPRD2 PCBP1 NUP153 | 8.52e-08 | 357 | 156 | 12 | 37059091 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | MAP1B MYCBP2 AIMP1 DYNC2H1 BCLAF1 PABPC4 GART E2F1 OPA1 TRIM56 NUMB RPRD2 | 8.78e-08 | 358 | 156 | 12 | 32460013 |
| Pubmed | FAT4 WDR7 BCLAF1 PABPC4 RPS11 SRP68 SPAG9 ZNF318 PKHD1L1 WDR3 NCOR1 UBR5 TJP1 WASF2 CLINT1 SCRIB ARAP2 | 8.78e-08 | 777 | 156 | 17 | 35844135 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 19217372 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 12172541 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 9.11e-08 | 123 | 156 | 8 | 26912792 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | EPHX1 RANBP2 RBM15 SPNS1 CDSN TCF20 MAP1B MYCBP2 WDR7 PUF60 BCLAF1 SRP68 OPA1 SYNGAP1 TJP1 KCTD10 MRPL48 GNL2 PPIH PLOD1 | 9.32e-08 | 1082 | 156 | 20 | 38697112 |
| Pubmed | 1.25e-07 | 11 | 156 | 4 | 26114487 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FLNA FLNB RBM15 MAP1B MYCBP2 DYNC2H1 ANXA1 VPS4B SRP68 WDR3 PPP5C UBR5 TJP1 KCTD10 GNL2 CLINT1 SCRIB PPIH NUP153 | 1.42e-07 | 1005 | 156 | 19 | 19615732 |
| Pubmed | EPHX1 FLNA FLNB RANBP2 AIMP1 PABPC4 GART GDI2 UBR5 CLINT1 SCRIB PPIH PCBP1 NUP153 | 1.48e-07 | 534 | 156 | 14 | 35032548 | |
| Pubmed | FLNA FLNB RANBP2 MAP1B MYCBP2 AIMP1 ANXA1 BCLAF1 GRIA1 GRIA3 GRIA4 SUCLG1 OPA1 SYNGAP1 SHANK2 PPP5C TJP1 IGHMBP2 KCTD10 FAM169A | 2.11e-07 | 1139 | 156 | 20 | 36417873 | |
| Pubmed | FLNA RBM15 CDSN COL11A1 AIMP1 PUF60 ANXA1 BCLAF1 PABPC4 SRP68 SUCLG1 WDR3 TJP1 TRIM56 GNL2 NUMB COL14A1 ROS1 CLINT1 PPIH PCBP1 PLOD1 | 2.32e-07 | 1371 | 156 | 22 | 36244648 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLNA FLNB RBM15 PUF60 ANXA1 BCLAF1 PABPC4 GART RPS11 SRP68 WDR3 KCTD10 GNL2 NUMB CLINT1 SCRIB FHL2 PCBP1 | 2.96e-07 | 949 | 156 | 18 | 36574265 |
| Pubmed | FLNA FLNB RANBP2 PUF60 SRP68 TWF2 TSC1 SPAG9 GDI2 UBR5 TJP1 TMEM131 CLINT1 NUP153 | 3.12e-07 | 568 | 156 | 14 | 37774976 | |
| Pubmed | FLNA FLNB CENPF PABPC4 GART TRPS1 PARP14 LIF WASF2 SCRIB SPRTN | 3.46e-07 | 332 | 156 | 11 | 37433992 | |
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 3.53e-07 | 4 | 156 | 3 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 3.53e-07 | 4 | 156 | 3 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 3.53e-07 | 4 | 156 | 3 | 17828255 | |
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 3.53e-07 | 4 | 156 | 3 | 12692557 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 14561864 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 24652293 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 12125045 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 10688364 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 17409242 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 1319477 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 9648857 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNA FLNB RANBP2 AIMP1 PUF60 ANXA1 PABPC4 GART RPS11 SRP68 TSC1 RDH13 OPA1 UBR5 SBNO1 TJP1 WASF2 GNL2 PPIH FHL2 PCBP1 PLOD1 | 3.95e-07 | 1415 | 156 | 22 | 28515276 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | FLNA RANBP2 PUF60 PABPC4 ZNF318 WDR3 GNL2 RPRD2 PCBP1 NUP153 | 4.51e-07 | 271 | 156 | 10 | 32433965 |
| Pubmed | FLNA FLNB RANBP2 RBM15 CENPF BCLAF1 NCOR1 NUMB RPRD2 TMEM131 SCRIB PCBP1 NUP153 | 4.94e-07 | 503 | 156 | 13 | 16964243 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA FLNB RANBP2 RBM15 CDSN TCF20 MAP1B MYCBP2 ANXA1 GART RPS11 SRP68 TSC1 WDR3 C5orf24 UBR5 SCRIB PPIH FHL2 PCBP1 PLOD1 | 7.66e-07 | 1353 | 156 | 21 | 29467282 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | RBM15 MYCBP2 BCLAF1 PABPC4 RPS11 ZNF318 RPRD2 TMEM131 SCRIB FHL2 NUP153 | 7.88e-07 | 361 | 156 | 11 | 30344098 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RANBP2 MYCBP2 BCLAF1 ZNF318 WDR3 UBR5 GNL2 RPRD2 SCRIB CDH1 PLOD1 NUP153 | 7.89e-07 | 440 | 156 | 12 | 34244565 |
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 16129400 | ||
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 9482932 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZNF703 FLNA RANBP2 MAP1B MYCBP2 ANXA1 BCLAF1 PABPC4 SRP68 DYSF TJP1 TMEM131 CLINT1 PCBP1 PLOD1 | 1.04e-06 | 724 | 156 | 15 | 36232890 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RANBP2 DCAF8 CENPF BCLAF1 PABPC4 TRPS1 SPAG9 GDI2 EML3 UBR5 TJP1 KCTD10 CLINT1 SCRIB PPIH FHL2 PCBP1 PLOD1 NUP153 | 1.15e-06 | 1155 | 156 | 19 | 20360068 |
| Pubmed | FLNA FLNB RANBP2 AIMP1 PUF60 GART RPS11 SRP68 SPAG9 WDR3 CLINT1 SCRIB PCBP1 NUP153 | 1.24e-06 | 638 | 156 | 14 | 33239621 | |
| Pubmed | FLNA FLNB RANBP2 MYH6 PUF60 ANXA1 PABPC4 GART RPS11 SRP68 ZNF318 CMYA5 GDI2 OPA1 FHL2 PCBP1 | 1.42e-06 | 844 | 156 | 16 | 25963833 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | FLNB MYH3 RANBP2 MYH6 MAP1B AIMP1 ANXA1 PABPC4 GDI1 GDI2 UBR5 SCRIB FHL2 CDH1 | 1.46e-06 | 647 | 156 | 14 | 26618866 |
| Pubmed | FLNB RANBP2 RBM15 AIMP1 PUF60 BCLAF1 PABPC4 RPS11 SRP68 WDR3 NCOR1 TJP1 GNL2 PPIH PCBP1 NUP153 | 1.48e-06 | 847 | 156 | 16 | 35850772 | |
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 28381556 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | FLNA FLNB RANBP2 RBM15 CDSN BCLAF1 PABPC4 GART SRP68 SPAG9 OPA1 CLINT1 | 1.83e-06 | 477 | 156 | 12 | 31300519 |
| Pubmed | FLNA FLNB RANBP2 RBM15 BCLAF1 GART TWF2 EFR3A WDR3 TJP1 CLINT1 SCRIB PPIH PLOD1 | 1.84e-06 | 660 | 156 | 14 | 32780723 | |
| Pubmed | 2.01e-06 | 46 | 156 | 5 | 35022314 | ||
| Pubmed | 2.18e-06 | 251 | 156 | 9 | 27507650 | ||
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 2.46e-06 | 327 | 156 | 10 | 15592455 | |
| Pubmed | FLNA FLNB CENPF AIMP1 ANXA1 PABPC4 GART RPS11 SRP68 SPAG9 PCBP1 NUP153 | 2.62e-06 | 494 | 156 | 12 | 26831064 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 21368048 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 3.06e-06 | 7 | 156 | 3 | 33981040 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 3.06e-06 | 7 | 156 | 3 | 9016303 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 27076426 | ||
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 3.06e-06 | 7 | 156 | 3 | 10407040 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 3.06e-06 | 7 | 156 | 3 | 9651535 | |
| Pubmed | 3.20e-06 | 263 | 156 | 9 | 34702444 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 3.72e-06 | 268 | 156 | 9 | 33024031 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RANBP2 RBM15 MYCBP2 AIMP1 VPS4B PABPC4 GART RPS11 RDH13 SUCLG1 GDI2 OPA1 WDR3 NCOR1 UBR5 SCRIB PPIH PCBP1 PLOD1 | 3.94e-06 | 1257 | 156 | 19 | 37317656 |
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 4.88e-06 | 8 | 156 | 3 | 23217150 | |
| Pubmed | Filamin B mutations cause chondrocyte defects in skeletal development. | 4.88e-06 | 8 | 156 | 3 | 17510210 | |
| Pubmed | Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. | 4.88e-06 | 8 | 156 | 3 | 21172611 | |
| Pubmed | FLNB DCAF8 MYCBP2 TRPS1 ZBTB4 CACHD1 EYA3 CMYA5 GDI1 SYNGAP1 SPTBN4 WDR3 PPP5C SBNO1 TJP1 SCG2 TMEM131 SCRIB PCBP1 | 5.40e-06 | 1285 | 156 | 19 | 35914814 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | FLNA RANBP2 FAM234A AIMP1 DYNC2H1 DNAH2 SRP68 CACHD1 ADAM10 OPA1 SC5D UBR5 CLINT1 SCRIB PLOD1 NUP153 | 5.72e-06 | 942 | 156 | 16 | 31073040 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.79e-06 | 283 | 156 | 9 | 30585729 | |
| Pubmed | FLNA FLNB SPNS1 MYCBP2 PABPC4 GART RPS11 SRP68 RDH13 ADAM10 WDR3 NCOR1 UBR5 TJP1 NUMB FHL2 MMAB PCBP1 PLOD1 | 6.16e-06 | 1297 | 156 | 19 | 33545068 | |
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 24292102 | ||
| Pubmed | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway. | 7.29e-06 | 9 | 156 | 3 | 28169360 | |
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 7.29e-06 | 9 | 156 | 3 | 9051806 | |
| Pubmed | 7.33e-06 | 28 | 156 | 4 | 23195221 | ||
| Pubmed | PI4K2B FLNA FLNB RANBP2 DCAF8 GALNT3 MAP1B AIMP1 BCLAF1 PABPC4 TWF2 RDH13 SUCLG1 ADAM10 WDR3 UBR5 GNL2 CLINT1 SCRIB PLOD1 | 7.57e-06 | 1440 | 156 | 20 | 30833792 | |
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 26376988 | ||
| Pubmed | Novel progerin-interactive partner proteins hnRNP E1, EGF, Mel 18, and UBC9 interact with lamin A/C. | 1.04e-05 | 10 | 156 | 3 | 16248985 | |
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 24436304 | ||
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 19363157 | ||
| Pubmed | The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. | 1.08e-05 | 110 | 156 | 6 | 18307411 | |
| Pubmed | Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. | 1.24e-05 | 170 | 156 | 7 | 19064572 | |
| Pubmed | 1.27e-05 | 32 | 156 | 4 | 26184908 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | FLNA RBM15 SPNS1 MAP1B PUF60 BCLAF1 PABPC4 RPS11 SRP68 WDR3 GNL2 PCBP1 PLOD1 | 1.28e-05 | 678 | 156 | 13 | 30209976 |
| Interaction | SIRT7 interactions | FLNA FLNB RANBP2 RBM15 TCF20 MAP1B MYCBP2 CENPF PUF60 ANXA1 PABPC4 GART SRP68 FRYL SPAG9 ZNF318 GDI1 GDI2 WDR3 UBR5 TJP1 WASF2 GNL2 PLOD1 NUP153 | 4.53e-10 | 744 | 154 | 25 | int:SIRT7 |
| Interaction | PHLPP1 interactions | FLNA FLNB RANBP2 RBM15 CENPF RPS11 SRP68 TSC1 ZNF318 CMYA5 EFR3A TRIM67 PPP5C TJP1 CLINT1 SCRIB CDH1 | 7.60e-10 | 333 | 154 | 17 | int:PHLPP1 |
| Interaction | KCNA3 interactions | CHL1 EPHX1 FLNB RANBP2 MAP1B PUF60 BCLAF1 PABPC4 GART RPS11 SRP68 CACHD1 GDI1 OPA1 EFR3A WASF2 NUMB C1QC CLINT1 RP1 SCRIB PCBP1 NUP153 | 2.04e-07 | 871 | 154 | 23 | int:KCNA3 |
| Interaction | RNF113A interactions | ZNF703 FLNA RANBP2 DCAF8 AIMP1 PUF60 BCLAF1 PABPC4 GART TRPS1 RPS11 SRP68 OPA1 UBR5 TRIM56 GNL2 FHL2 PCBP1 PLOD1 NUP153 | 3.37e-07 | 692 | 154 | 20 | int:RNF113A |
| Interaction | MCM2 interactions | FLNA FLNB RANBP2 MYH6 PUF60 ANXA1 PABPC4 GART RPS11 SRP68 SPAG9 ZNF318 CMYA5 TRIM24 GDI2 AR OPA1 TRIM67 UBR5 SBNO1 TJP1 SPRTN FHL2 PCBP1 KDF1 | 6.82e-07 | 1081 | 154 | 25 | int:MCM2 |
| Interaction | SYNGAP1 interactions | MAP1B MYCBP2 WDR7 BCLAF1 GRIA1 GRIA3 TSC1 ADAM10 GDI2 OPA1 SYNGAP1 SHANK2 UBR5 | 7.07e-07 | 307 | 154 | 13 | int:SYNGAP1 |
| Interaction | WWTR1 interactions | TCF20 MAP1B MYCBP2 PUF60 SRP68 TWF2 SPAG9 ZNF318 NCOR1 TJP1 NUMB RPRD2 CLINT1 SCRIB PCBP1 | 8.84e-07 | 422 | 154 | 15 | int:WWTR1 |
| Interaction | RNF43 interactions | RANBP2 TCF20 PABPC4 ZNF318 TRIM24 NKD2 UBR5 TJP1 NUMB TMEM131 CLINT1 SCRIB PCBP1 CDH1 NUP153 | 1.02e-06 | 427 | 154 | 15 | int:RNF43 |
| Interaction | OBSL1 interactions | FLNA FLNB RANBP2 RBM15 TCF20 CENPF AIMP1 PUF60 ANXA1 BCLAF1 GART AR WDR3 TRIM67 TJP1 TRIM56 GNL2 SCRIB CFAP70 PCBP1 PLOD1 NUP153 | 1.45e-06 | 902 | 154 | 22 | int:OBSL1 |
| Interaction | SLX4 interactions | FLNA RANBP2 RBM15 CDSN TCF20 GART ZNF318 TRIM24 NCOR1 NKD2 UBR5 SBNO1 RPRD2 CLINT1 SPRTN PCBP1 NUP153 | 1.88e-06 | 572 | 154 | 17 | int:SLX4 |
| Interaction | KCTD13 interactions | FLNA FLNB MYH6 MAP1B WDR7 ANXA1 BCLAF1 PABPC4 RPS11 SRP68 GRIA1 TWF2 TSC1 SUCLG1 GDI1 GDI2 OPA1 SYNGAP1 SPTBN4 SHANK2 TJP1 KCTD10 MRPL48 C1QC SCRIB SPRTN BRSK1 PCBP1 | 2.20e-06 | 1394 | 154 | 28 | int:KCTD13 |
| Interaction | BAP1 interactions | FLNA FLNB RANBP2 DCAF8 MAP1B MYCBP2 AIMP1 PUF60 ANXA1 PABPC4 GART RPS11 SRP68 E2F1 SPAG9 ME1 GDI1 GDI2 AR TRIM67 PPP5C UBR5 WASF2 PPIH FHL2 PCBP1 NUP153 | 2.25e-06 | 1314 | 154 | 27 | int:BAP1 |
| Interaction | CHMP4B interactions | FLNA FLNB MYCBP2 PUF60 BCLAF1 VPS4B GART RPS11 SUCLG1 ADAM10 SPTBN4 WDR3 TRIM67 UBR5 TJP1 SCRIB PCBP1 CDH1 PLOD1 | 3.00e-06 | 727 | 154 | 19 | int:CHMP4B |
| Interaction | SOX2 interactions | FLNA RANBP2 RBM15 COL11A1 TCF20 MAP1B AIMP1 PUF60 PRSS12 ANXA1 BCLAF1 PABPC4 TRPS1 RPS11 SRP68 TRIM24 GDI1 GDI2 ADH7 WDR3 NCOR1 UBR5 DMKN TRIM56 NUMB CLINT1 BRSK1 PPIH | 3.23e-06 | 1422 | 154 | 28 | int:SOX2 |
| Interaction | RAN interactions | FLNB RANBP2 DCAF8 MYCBP2 AIMP1 PABPC4 TSC1 ACSS2 AR TRIM67 SPRTN PCBP1 KDF1 CDH1 NUP153 | 3.79e-06 | 475 | 154 | 15 | int:RAN |
| Interaction | FBXO22 interactions | RBM15 CENPF TSC1 AK9 DYSF ME1 OPA1 NSUN7 SYNGAP1 NCOR1 DNAH12 TRIM67 IGHMBP2 GNL2 RP1 PLOD1 | 4.01e-06 | 540 | 154 | 16 | int:FBXO22 |
| Interaction | FXR1 interactions | FLNA FLNB RANBP2 MYCBP2 CENPF BCLAF1 PABPC4 GBP2 TSC1 ADAM10 AR NCOR1 TRIM67 NKD2 TRIM56 KCTD10 SCRIB NUP153 | 4.59e-06 | 679 | 154 | 18 | int:FXR1 |
| Interaction | CIT interactions | FLNA FLNB RANBP2 RBM15 TCF20 CENPF DYNC2H1 PUF60 ANXA1 BCLAF1 PABPC4 GART RPS11 SRP68 CMYA5 ADAM10 SPTBN4 WDR3 DNAH12 TRIM67 TJP1 KCTD10 GNL2 SCRIB PPIH PCBP1 PLOD1 NUP153 | 4.68e-06 | 1450 | 154 | 28 | int:CIT |
| Interaction | NAA40 interactions | FLNA RANBP2 MAP1B PUF60 BCLAF1 GART RPS11 SRP68 TSC1 SPAG9 ZNF318 TJP1 WASF2 FAM169A GNL2 NUMB RPRD2 CLINT1 SCRIB PCBP1 KDF1 NUP153 | 5.37e-06 | 978 | 154 | 22 | int:NAA40 |
| Interaction | RCOR1 interactions | FLNA RANBP2 MYCBP2 CENPF VPS4B TRPS1 RPS11 SPAG9 ZNF318 AR NCOR1 TRIM67 UBR5 FAM169A FHL2 | 6.08e-06 | 494 | 154 | 15 | int:RCOR1 |
| Interaction | CFTR interactions | EPHX1 FLNA FLNB MYH3 RANBP2 MYH6 CDSN MAP1B AIMP1 PUF60 ANXA1 VPS4B PDZK1 PABPC4 RPS11 SRP68 RDH13 GDI1 GDI2 UBR5 TJP1 CLINT1 SCRIB CSNK1G2-AS1 FHL2 PCBP1 CDH1 VAV1 | 6.89e-06 | 1480 | 154 | 28 | int:CFTR |
| Interaction | STIP1 interactions | FLNA FLNB RANBP2 AIMP1 PUF60 GART RPS11 SRP68 SPAG9 EYA3 ME1 GDI2 AR SYNGAP1 WDR3 TRIM67 PPP5C KCTD10 CLINT1 SCRIB PCBP1 NUP153 | 8.39e-06 | 1006 | 154 | 22 | int:STIP1 |
| Interaction | PML interactions | FLNA RANBP2 CDSN MAP1B ANXA1 OAS1 E2F1 SPAG9 ZNF318 EYA3 PARP14 TRIM24 OPA1 NCOR1 TRIM67 UBR5 SBNO1 TJP1 CLINT1 FHL2 PCBP1 | 8.90e-06 | 933 | 154 | 21 | int:PML |
| Interaction | KIF23 interactions | FLNA FLNB AIMP1 PUF60 ANXA1 BCLAF1 PABPC4 GART RPS11 SRP68 FRYL SPAG9 AK9 OPA1 EFR3A WDR3 TRIM67 UBR5 TJP1 TRIM56 KCTD10 PCBP1 | 1.23e-05 | 1031 | 154 | 22 | int:KIF23 |
| Interaction | IQGAP1 interactions | FLNA FLNB MAP1B MYCBP2 AIMP1 BCLAF1 GRIA4 SPAG9 SYNGAP1 WDR3 TRIM67 NUMB CLINT1 FHL2 PCBP1 CDH1 | 1.24e-05 | 591 | 154 | 16 | int:IQGAP1 |
| Interaction | PHF21A interactions | FLNA FLNB RANBP2 MYCBP2 CENPF VPS4B TRPS1 RPS11 ZNF318 AR UBR5 FHL2 | 1.34e-05 | 343 | 154 | 12 | int:PHF21A |
| Interaction | RAB1A interactions | FLNA FLNB AIMP1 GART RDH13 ADAM10 GDI1 GDI2 SYNGAP1 NCOR1 TRIM67 SPRTN PCBP1 CDH1 | 1.35e-05 | 464 | 154 | 14 | int:RAB1A |
| Interaction | ECT2 interactions | FLNA FLNB MYCBP2 PUF60 BCLAF1 PABPC4 RPS11 LCA5L SRP68 SPAG9 CMYA5 SUCLG1 SPTBN4 TRIM67 TJP1 KCTD10 SCRIB PCBP1 CDH1 PLOD1 | 1.45e-05 | 887 | 154 | 20 | int:ECT2 |
| Interaction | FMR1 interactions | RANBP2 TCF20 MAP1B MYCBP2 BCLAF1 TSC1 ADAM10 SYNGAP1 NCOR1 TRIM67 TJP1 TRIM56 SCRIB BRSK1 PCBP1 | 1.60e-05 | 536 | 154 | 15 | int:FMR1 |
| Interaction | FSCN1 interactions | FLNA MYCBP2 AIMP1 PABPC4 RPS11 ADAM10 TRIM67 GNL2 PCBP1 CDH1 | 2.40e-05 | 251 | 154 | 10 | int:FSCN1 |
| Interaction | CDH1 interactions | FLNA FLNB SGCA PUF60 ANXA1 E2F1 TWF2 EFR3A SHANK2 NKD2 TJP1 WASF2 NUMB CLINT1 SCRIB PCBP1 KDF1 CDH1 | 2.42e-05 | 768 | 154 | 18 | int:CDH1 |
| Interaction | NUP43 interactions | ZNF703 FLNA RANBP2 RBM15 TCF20 BCLAF1 MUC19 ZNF318 SUCLG1 WDR3 NCOR1 TRIM67 UBR5 FAM169A GNL2 NUP153 | 2.46e-05 | 625 | 154 | 16 | int:NUP43 |
| Interaction | CDKL5 interactions | 2.60e-05 | 113 | 154 | 7 | int:CDKL5 | |
| Interaction | SIRT6 interactions | PI4K2B FLNA FLNB RANBP2 FAT4 MYCBP2 BCLAF1 ZNF318 WDR3 UBR5 GNL2 RPRD2 SCRIB CDH1 PLOD1 NUP153 | 2.60e-05 | 628 | 154 | 16 | int:SIRT6 |
| Interaction | ISG15 interactions | EPHX1 FLNA FLNB AIMP1 ANXA1 BCLAF1 ZNF318 GDI2 TRIM67 TJP1 CLINT1 SPRTN PCBP1 PLOD1 | 2.70e-05 | 494 | 154 | 14 | int:ISG15 |
| Interaction | AXL interactions | FLNA RBM15 AIMP1 PABPC4 TEC ADAM10 EFR3A TRIM67 TJP1 NUMB SCRIB PCBP1 | 2.76e-05 | 369 | 154 | 12 | int:AXL |
| Interaction | RAB8B interactions | 3.17e-05 | 79 | 154 | 6 | int:RAB8B | |
| Interaction | DHX15 interactions | FLNB RANBP2 RBM15 AIMP1 PUF60 PABPC4 RPS11 DYSF TRIM24 AR TRIM67 UBR5 PCBP1 KDF1 | 3.22e-05 | 502 | 154 | 14 | int:DHX15 |
| Interaction | TLE3 interactions | ZNF703 FLNA MYH3 TCF20 TRPS1 ZBTB4 ZNF318 EYA3 AR SPTBN4 NCOR1 UBR5 | 3.32e-05 | 376 | 154 | 12 | int:TLE3 |
| Interaction | RNF2 interactions | EPHX1 FLNB RANBP2 BCLAF1 PABPC4 RPS11 SRP68 AKIP1 DYSF TRIM24 AR EFR3A TRIM67 UBR5 TRIM56 KCTD10 MRPL48 CLINT1 CDH1 | 3.50e-05 | 866 | 154 | 19 | int:RNF2 |
| Interaction | TRRAP interactions | EPHX1 RBM15 FAT4 COL11A1 WDR7 DYNC2H1 GART DNAH2 GBP2 E2F1 GDI2 AR NCOR1 TRIM67 UBR5 ROS1 PPIH PLOD1 | 3.50e-05 | 790 | 154 | 18 | int:TRRAP |
| Interaction | GSK3B interactions | FLNA MAP1B AIMP1 ANXA1 GART GBP2 E2F1 TSC1 GDI2 AR FBXL21P SYNGAP1 SPTBN4 TRIM67 UBR5 TJP1 SCRIB BRSK1 CDH1 | 3.61e-05 | 868 | 154 | 19 | int:GSK3B |
| Interaction | EFTUD2 interactions | FLNA FLNB RANBP2 AIMP1 PUF60 ANXA1 PABPC4 GART RPS11 SRP68 RDH13 TRIM24 AR OPA1 TRIM67 UBR5 SBNO1 TJP1 WASF2 GNL2 SPRTN PPIH FHL2 PCBP1 KDF1 PLOD1 | 3.83e-05 | 1449 | 154 | 26 | int:EFTUD2 |
| Interaction | MEX3A interactions | FLNA FLNB CENPF PABPC4 GART TRPS1 PARP14 LIF TRIM67 WASF2 SCRIB SPRTN | 4.07e-05 | 384 | 154 | 12 | int:MEX3A |
| Interaction | MATR3 interactions | RANBP2 MYCBP2 PUF60 BCLAF1 PABPC4 RPS11 DNAH2 TSC1 TRIM24 AR NCOR1 TRIM67 UBR5 SPRTN PCBP1 KDF1 | 4.31e-05 | 655 | 154 | 16 | int:MATR3 |
| Interaction | CTTN interactions | FLNA FLNB RANBP2 RBM15 MYCBP2 GART ME1 TRIM67 SHANK2 PPP5C TJP1 PCBP1 CDH1 | 4.35e-05 | 450 | 154 | 13 | int:CTTN |
| Interaction | POLH interactions | 4.49e-05 | 84 | 154 | 6 | int:POLH | |
| Interaction | EIF4A2 interactions | 5.20e-05 | 171 | 154 | 8 | int:EIF4A2 | |
| Interaction | ERG interactions | 5.59e-05 | 223 | 154 | 9 | int:ERG | |
| Interaction | ABI1 interactions | 5.59e-05 | 223 | 154 | 9 | int:ABI1 | |
| Interaction | AR interactions | FLNA TCF20 MYCBP2 PUF60 TRPS1 RPS11 E2F1 ZNF318 TRIM24 ME1 GDI1 AR NCOR1 PPP5C UBR5 TJP1 RPRD2 FHL2 PCBP1 VAV1 | 7.00e-05 | 992 | 154 | 20 | int:AR |
| Interaction | KIF5B interactions | FLNA RANBP2 SRP68 GRIA1 SPAG9 ADAM10 NCOR1 TRIM67 FHL2 PCBP1 CDH1 | 7.76e-05 | 348 | 154 | 11 | int:KIF5B |
| Interaction | SMC5 interactions | FLNA RANBP2 RBM15 TCF20 MAP1B PUF60 BCLAF1 PABPC4 ZNF318 TRIM24 WDR3 NCOR1 C5orf24 TRIM67 TJP1 GNL2 RPRD2 CLINT1 PCBP1 NUP153 | 7.81e-05 | 1000 | 154 | 20 | int:SMC5 |
| Interaction | CUL7 interactions | FLNA FLNB RANBP2 RBM15 MAP1B CENPF PUF60 ANXA1 BCLAF1 PABPC4 GART TRPS1 WDR3 TRIM67 TJP1 GNL2 MMAB PCBP1 | 8.31e-05 | 845 | 154 | 18 | int:CUL7 |
| Interaction | PRKDC interactions | FLNA RANBP2 FAM234A MAP1B PUF60 RPS11 TEK AR NCOR1 TRIM67 UBR5 ROS1 SPRTN PCBP1 KDF1 CDH1 | 8.66e-05 | 695 | 154 | 16 | int:PRKDC |
| Interaction | USP4 interactions | 8.81e-05 | 293 | 154 | 10 | int:USP4 | |
| Interaction | DBN1 interactions | FLNA FLNB MYCBP2 GART ADAM10 SYNGAP1 TRIM67 UBR5 KCTD10 NUMB CLINT1 CDH1 | 8.95e-05 | 417 | 154 | 12 | int:DBN1 |
| Interaction | CYP3A5 interactions | 9.15e-05 | 12 | 154 | 3 | int:CYP3A5 | |
| Interaction | HOMER1 interactions | 1.02e-04 | 140 | 154 | 7 | int:HOMER1 | |
| Interaction | TTN interactions | 1.04e-04 | 299 | 154 | 10 | int:TTN | |
| Interaction | DYSF interactions | 1.11e-04 | 62 | 154 | 5 | int:DYSF | |
| Interaction | IFI16 interactions | FLNA RBM15 MAP1B PUF60 PABPC4 GART SRP68 AR WDR3 TRIM67 TJP1 IGHMBP2 TRIM56 GNL2 FHL2 NUP153 | 1.18e-04 | 714 | 154 | 16 | int:IFI16 |
| Interaction | MECP2 interactions | EPHX1 RANBP2 RBM15 SPNS1 CDSN TCF20 MAP1B MYCBP2 WDR7 PUF60 BCLAF1 RPS11 SRP68 OPA1 SYNGAP1 NCOR1 TRIM67 TJP1 KCTD10 MRPL48 GNL2 PPIH PLOD1 | 1.20e-04 | 1287 | 154 | 23 | int:MECP2 |
| Interaction | YWHAQ interactions | FLNA MTMR12 CDSN MYCBP2 ANXA1 PABPC4 E2F1 TSC1 FRYL SPAG9 AR EML3 TRIM67 NKD2 PPP5C TJP1 WASF2 NUMB SCRIB PCBP1 ARAP2 | 1.24e-04 | 1118 | 154 | 21 | int:YWHAQ |
| Interaction | EGLN3 interactions | ZNF703 RANBP2 DCAF8 MYCBP2 CENPF WDR7 GART ZNF318 CACHD1 EYA3 SUCLG1 OPA1 NCOR1 PPP5C UBR5 NUMB TMEM131 CLINT1 SCRIB FHL2 PCBP1 TET3 NUP153 | 1.34e-04 | 1296 | 154 | 23 | int:EGLN3 |
| Interaction | HSP90AB1 interactions | FLNA MAP1B MYCBP2 CENPF ANXA1 VPS4B RPS11 DNAH2 GBP2 TSC1 AR TRIM67 PPP5C SCG2 ROS1 SPRTN PCBP1 CDH1 TET3 | 1.37e-04 | 960 | 154 | 19 | int:HSP90AB1 |
| Interaction | ITGB6 interactions | 1.50e-04 | 14 | 154 | 3 | int:ITGB6 | |
| Interaction | NHLRC2 interactions | WDR7 BCLAF1 TWF2 FRYL GDI2 SPTBN4 TRIM67 DMKN NUMB SPRTN PLOD1 | 1.50e-04 | 375 | 154 | 11 | int:NHLRC2 |
| Interaction | KIF20A interactions | FLNA FLNB RANBP2 DYNC2H1 PUF60 BCLAF1 PABPC4 RPS11 LCA5L SPAG9 ZNF318 EFR3A SPTBN4 WDR3 TRIM67 UBR5 TJP1 CLINT1 PCBP1 TET3 | 1.55e-04 | 1052 | 154 | 20 | int:KIF20A |
| Interaction | EEF2 interactions | FLNA MAP1B MYCBP2 PUF60 ANXA1 GART TSC1 GDI1 AR OPA1 TRIM67 SPRTN PCBP1 CDH1 | 1.73e-04 | 588 | 154 | 14 | int:EEF2 |
| Interaction | PPP1CC interactions | FLNA RBM15 MYCBP2 BCLAF1 PABPC4 RPS11 ZNF318 NCOR1 TRIM67 UBR5 RPRD2 TMEM131 SCRIB FHL2 PCBP1 NUP153 | 1.73e-04 | 738 | 154 | 16 | int:PPP1CC |
| Interaction | MED4 interactions | FLNB MAP1B MYCBP2 BCLAF1 SRP68 SPAG9 AR TRIM67 UBR5 RPRD2 CLINT1 SCRIB | 1.82e-04 | 450 | 154 | 12 | int:MED4 |
| Interaction | NSUN2 interactions | 1.95e-04 | 323 | 154 | 10 | int:NSUN2 | |
| Interaction | CEBPA interactions | FLNA RANBP2 RBM15 TCF20 MYCBP2 PUF60 ANXA1 BCLAF1 PABPC4 SRP68 TWF2 ZNF318 EYA3 TRIM24 GDI2 AR NCOR1 PPP5C UBR5 CLINT1 PPIH NUP153 | 2.01e-04 | 1245 | 154 | 22 | int:CEBPA |
| Interaction | GLUL interactions | 2.33e-04 | 160 | 154 | 7 | int:GLUL | |
| Interaction | B9D2 interactions | 2.41e-04 | 73 | 154 | 5 | int:B9D2 | |
| Interaction | EEF1A1 interactions | FLNA FLNB RANBP2 MAP1B PUF60 PABPC4 GART RPS11 DYSF TRIM67 UBR5 KCTD10 SPRTN FHL2 PCBP1 CDH1 | 2.47e-04 | 762 | 154 | 16 | int:EEF1A1 |
| Interaction | EED interactions | CHL1 FLNA FLNB RANBP2 RBM15 MAP1B MYCBP2 PUF60 BCLAF1 GART RPS11 SRP68 TWF2 GDI2 AR WDR3 NCOR1 TRIM67 TJP1 NUMB CLINT1 PCBP1 PLOD1 VAV1 | 2.55e-04 | 1445 | 154 | 24 | int:EED |
| Interaction | IL6ST interactions | 2.57e-04 | 74 | 154 | 5 | int:IL6ST | |
| Interaction | NUDC interactions | 2.74e-04 | 337 | 154 | 10 | int:NUDC | |
| Interaction | FBXO41 interactions | 2.75e-04 | 17 | 154 | 3 | int:FBXO41 | |
| Interaction | MAT2A interactions | 2.78e-04 | 218 | 154 | 8 | int:MAT2A | |
| Interaction | MAPK1 interactions | TCF20 TRPS1 RPS11 SPAG9 ADAM10 ME1 AR SYNGAP1 TRIM67 UBR5 FHL2 VAV1 NUP153 | 2.81e-04 | 543 | 154 | 13 | int:MAPK1 |
| Interaction | HDLBP interactions | FLNA RBM15 CDSN COL11A1 AIMP1 PUF60 ANXA1 PABPC4 RPS11 SRP68 SUCLG1 TRIM67 COL14A1 ROS1 CLINT1 PCBP1 CDH1 | 2.98e-04 | 855 | 154 | 17 | int:HDLBP |
| Interaction | NUP50 interactions | FLNB RANBP2 TCF20 ZNF318 WDR3 NCOR1 TRIM67 SBNO1 RPRD2 NUP153 | 3.01e-04 | 341 | 154 | 10 | int:NUP50 |
| Interaction | B4GALT2 interactions | 3.08e-04 | 119 | 154 | 6 | int:B4GALT2 | |
| Interaction | KDM1A interactions | FLNA FLNB RANBP2 SPNS1 TCF20 MYCBP2 CENPF AIMP1 VPS4B TRPS1 E2F1 TSC1 ZNF318 TRIM24 AR NCOR1 TRIM67 UBR5 | 3.14e-04 | 941 | 154 | 18 | int:KDM1A |
| Interaction | GRIA3 interactions | 3.21e-04 | 43 | 154 | 4 | int:GRIA3 | |
| Interaction | PPP1R9B interactions | FLNA MAP1B MYCBP2 WDR7 RPS11 SUCLG1 GDI1 GDI2 OPA1 SYNGAP1 TRIM67 SHANK2 PCBP1 VAV1 | 3.27e-04 | 626 | 154 | 14 | int:PPP1R9B |
| Interaction | FBXW5 interactions | 3.37e-04 | 170 | 154 | 7 | int:FBXW5 | |
| Interaction | ACTN2 interactions | 3.49e-04 | 171 | 154 | 7 | int:ACTN2 | |
| Interaction | ZMIZ1 interactions | 3.51e-04 | 44 | 154 | 4 | int:ZMIZ1 | |
| Interaction | FAM120A interactions | SPNS1 MAP1B PABPC4 DYSF TRIM24 TRIM67 TRIM56 SPRTN PCBP1 KDF1 | 3.61e-04 | 349 | 154 | 10 | int:FAM120A |
| Interaction | ATXN2L interactions | 3.63e-04 | 286 | 154 | 9 | int:ATXN2L | |
| Interaction | RRM2 interactions | 3.68e-04 | 123 | 154 | 6 | int:RRM2 | |
| Interaction | CAD interactions | MAP1B MYCBP2 GRIA4 TSC1 SPAG9 ACSS2 TRIM67 PPP5C UBR5 SPRTN VAV1 | 3.79e-04 | 418 | 154 | 11 | int:CAD |
| Interaction | MYBPC2 interactions | 3.83e-04 | 45 | 154 | 4 | int:MYBPC2 | |
| Interaction | POFUT2 interactions | 3.88e-04 | 19 | 154 | 3 | int:POFUT2 | |
| Interaction | DEPTOR interactions | 4.15e-04 | 82 | 154 | 5 | int:DEPTOR | |
| Interaction | EHD4 interactions | 4.55e-04 | 128 | 154 | 6 | int:EHD4 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 6.54e-07 | 4 | 100 | 3 | 1200 | |
| GeneFamily | Fibronectin type III domain containing | 2.99e-05 | 160 | 100 | 7 | 555 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 1.49e-04 | 19 | 100 | 3 | 909 | |
| GeneFamily | Cytochrome P450 family 3 | 8.30e-04 | 8 | 100 | 2 | 1002 | |
| GeneFamily | PDZ domain containing | 1.56e-03 | 152 | 100 | 5 | 1220 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.91e-03 | 95 | 100 | 4 | 59 | |
| GeneFamily | Myosin heavy chains | 3.03e-03 | 15 | 100 | 2 | 1098 | |
| GeneFamily | Dyneins, axonemal | 3.90e-03 | 17 | 100 | 2 | 536 | |
| Coexpression | GSE30083_SP3_VS_SP4_THYMOCYTE_DN | 3.16e-07 | 200 | 154 | 10 | M5037 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FLNB RANBP2 MAP1B MYCBP2 CENPF WDR7 FRYL SPAG9 TRIM24 ADAM10 OPA1 EFR3A UBR5 FAM169A NUMB TMEM131 CLINT1 NUP153 ARAP2 | 7.17e-07 | 856 | 154 | 19 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | FLNB MAP1B MYCBP2 CENPF WDR7 FRYL ADAM10 OPA1 UBR5 FAM169A NUMB TMEM131 NUP153 | 4.04e-06 | 466 | 154 | 13 | M13522 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FLNA RANBP2 MYCBP2 ANXA1 BCLAF1 TRPS1 ZBTB4 RPS11 GBP2 UNC13D TWF2 FRYL PARP14 GDI1 EML3 EFR3A NCOR1 UBR5 SBNO1 SEL1L3 PCBP1 VAV1 NUP153 ARAP2 | 6.75e-06 | 1492 | 154 | 24 | M40023 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | EPHX1 GPLD1 ZNF703 RBM15 SPNS1 GALNT3 SGCA PEX6 GBP2 OAS1 E2F1 TWF2 PPIF LIF PPP5C KCTD10 ELAPOR1 GNL2 FHL2 ARAP2 | 1.43e-05 | 1151 | 154 | 20 | M1103 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | EPHX1 GPLD1 ZNF703 RBM15 SPNS1 GALNT3 SGCA PEX6 GBP2 OAS1 E2F1 TWF2 PPIF LIF PPP5C KCTD10 ELAPOR1 GNL2 FHL2 ARAP2 | 3.52e-05 | 1226 | 154 | 20 | MM979 |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.85e-08 | 185 | 155 | 9 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.19e-08 | 197 | 155 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-07 | 178 | 155 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-07 | 179 | 155 | 8 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.88e-07 | 185 | 155 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.39e-07 | 189 | 155 | 8 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 3.83e-07 | 192 | 155 | 8 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.83e-07 | 192 | 155 | 8 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.83e-07 | 192 | 155 | 8 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.83e-07 | 192 | 155 | 8 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.14e-07 | 194 | 155 | 8 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.14e-07 | 194 | 155 | 8 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.14e-07 | 194 | 155 | 8 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.14e-07 | 194 | 155 | 8 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.47e-07 | 196 | 155 | 8 | 7b17d47b7758d8ccf9dbefd097aeb553791a1eed | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.65e-07 | 197 | 155 | 8 | 2f91b3870a7058168093a143110954c07588cfe9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.65e-07 | 197 | 155 | 8 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.83e-07 | 198 | 155 | 8 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | E16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.95e-07 | 148 | 155 | 7 | cd5f697d8c2f272be1f3f52a05446749278431c5 | |
| ToppCell | E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.95e-07 | 148 | 155 | 7 | 56e146980a71b5ca655118ae13310c5949220d4a | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-06 | 162 | 155 | 7 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 165 | 155 | 7 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 165 | 155 | 7 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-06 | 169 | 155 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-06 | 169 | 155 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-06 | 178 | 155 | 7 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 3.42e-06 | 181 | 155 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.55e-06 | 182 | 155 | 7 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.55e-06 | 182 | 155 | 7 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.55e-06 | 182 | 155 | 7 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.68e-06 | 183 | 155 | 7 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-06 | 184 | 155 | 7 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-06 | 185 | 155 | 7 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 4.09e-06 | 186 | 155 | 7 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 187 | 155 | 7 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 187 | 155 | 7 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 187 | 155 | 7 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.39e-06 | 188 | 155 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.55e-06 | 189 | 155 | 7 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.55e-06 | 189 | 155 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.55e-06 | 189 | 155 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.71e-06 | 190 | 155 | 7 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.71e-06 | 190 | 155 | 7 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.87e-06 | 191 | 155 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.87e-06 | 191 | 155 | 7 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.87e-06 | 191 | 155 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.87e-06 | 191 | 155 | 7 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.87e-06 | 191 | 155 | 7 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.04e-06 | 192 | 155 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.04e-06 | 192 | 155 | 7 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.04e-06 | 192 | 155 | 7 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-06 | 193 | 155 | 7 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.22e-06 | 193 | 155 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.22e-06 | 193 | 155 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.22e-06 | 193 | 155 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-06 | 193 | 155 | 7 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.22e-06 | 193 | 155 | 7 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.40e-06 | 194 | 155 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 5.58e-06 | 195 | 155 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.58e-06 | 195 | 155 | 7 | 62d369a8af2b76a2553bc8ff9cb89a133b060123 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 5.58e-06 | 195 | 155 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 11.5-Distal-Epithelial-Bud_tip_progenitor|Distal / Age, Tissue, Lineage and Cell class | 5.77e-06 | 196 | 155 | 7 | 42eae265e2f2082983d8c2607c7f6a53a526d124 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.77e-06 | 196 | 155 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 5.77e-06 | 196 | 155 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-06 | 197 | 155 | 7 | 06ed8f293d4ee89f14dc2f43d6cae93bbc02508a | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-06 | 197 | 155 | 7 | c115d0a45545ed24259ad88872231bf4d4d389d2 | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 6.17e-06 | 198 | 155 | 7 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.17e-06 | 198 | 155 | 7 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.17e-06 | 198 | 155 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 6.17e-06 | 198 | 155 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.17e-06 | 198 | 155 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.17e-06 | 198 | 155 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.17e-06 | 198 | 155 | 7 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 6.17e-06 | 198 | 155 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-06 | 130 | 155 | 6 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.37e-06 | 199 | 155 | 7 | debdd7dba774d9ccff7effc3f4c132393d203dfa | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.37e-06 | 199 | 155 | 7 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.37e-06 | 199 | 155 | 7 | 494461665f945ce6c97299c58f7785e90dec5812 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.37e-06 | 199 | 155 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.59e-06 | 200 | 155 | 7 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-06 | 200 | 155 | 7 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.59e-06 | 200 | 155 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.59e-06 | 200 | 155 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.59e-06 | 200 | 155 | 7 | d5426cd318a8f90c0bd8f9804351ab230fafc995 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.59e-06 | 200 | 155 | 7 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.59e-06 | 200 | 155 | 7 | 21d9cf3cd3696ad6b745c7c036798f04b6ce5160 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.59e-06 | 200 | 155 | 7 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-06 | 200 | 155 | 7 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.59e-06 | 200 | 155 | 7 | 33658d5d09e2eaff60f4dd88837d4252328eab63 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.59e-06 | 200 | 155 | 7 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.24e-06 | 136 | 155 | 6 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.24e-06 | 136 | 155 | 6 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.24e-06 | 136 | 155 | 6 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.24e-06 | 136 | 155 | 6 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.24e-06 | 136 | 155 | 6 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 145 | 155 | 6 | 4f8b188a93a038afbc7a446df8467ad544f5b1cb | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 1.34e-05 | 148 | 155 | 6 | db046a02a00829910bf9d7dbda068e730aa78f00 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.74e-05 | 155 | 155 | 6 | be575a0096415705dba425002247289ff8f89474 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 161 | 155 | 6 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 162 | 155 | 6 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| Drug | 3-pyridazinol 1-oxide | 1.18e-06 | 4 | 153 | 3 | CID000574311 | |
| Drug | Phenytoin | EPHX1 CYP3A7 COL11A1 MAP1B CYP3A4 PRSS12 E2F1 ME1 AR SC5D GNL2 IHH NUP153 | 2.14e-06 | 385 | 153 | 13 | ctd:D010672 |
| Drug | AC1L1YEG | 2.95e-06 | 5 | 153 | 3 | CID000063114 | |
| Drug | Chicago acid | 2.95e-06 | 5 | 153 | 3 | CID000065740 | |
| Drug | CHEBI:570577 | 2.95e-06 | 5 | 153 | 3 | CID011334126 | |
| Drug | 1-BCP | 2.95e-06 | 5 | 153 | 3 | CID000001370 | |
| Drug | irampanel | 2.95e-06 | 5 | 153 | 3 | CID003038472 | |
| Drug | LY395153 | 2.95e-06 | 5 | 153 | 3 | CID000656707 | |
| Drug | beta-N-oxalylaminoalanine | 2.95e-06 | 5 | 153 | 3 | CID000107978 | |
| Drug | 5-h PCA | 2.95e-06 | 5 | 153 | 3 | CID000129091 | |
| Drug | decahydroisoquinoline | 3.35e-06 | 16 | 153 | 4 | CID000097812 | |
| Drug | Azacitidine | RANBP2 CENPF CYP3A4 PRSS12 ANXA1 GBP2 E2F1 TSC1 TEK AR TJP1 COL14A1 CDH1 | 4.85e-06 | 415 | 153 | 13 | ctd:D001374 |
| Drug | YM928 | 5.86e-06 | 6 | 153 | 3 | CID006918393 | |
| Drug | 2cmo | 5.86e-06 | 6 | 153 | 3 | CID006914597 | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 1.02e-05 | 7 | 153 | 3 | CID000127988 | |
| Drug | thio-ATPA | 1.02e-05 | 7 | 153 | 3 | CID005289517 | |
| Drug | homoibotenic acid | 1.63e-05 | 8 | 153 | 3 | CID000194385 | |
| Drug | 1-hydroxypyrazole | 1.63e-05 | 8 | 153 | 3 | CID003016733 | |
| Drug | 1-hydroxyimidazole | 1.63e-05 | 8 | 153 | 3 | CID003614351 | |
| Drug | 2,3-PDCA | 1.63e-05 | 8 | 153 | 3 | CID000127037 | |
| Drug | 1m5b | 2.43e-05 | 9 | 153 | 3 | CID000447081 | |
| Drug | Ly294486 | 2.43e-05 | 9 | 153 | 3 | CID005311255 | |
| Drug | isothiazol-3-one | 2.43e-05 | 9 | 153 | 3 | CID000096917 | |
| Drug | memantine | 2.52e-05 | 86 | 153 | 6 | CID000004054 | |
| Drug | Benzoates | 3.45e-05 | 10 | 153 | 3 | ctd:D001565 | |
| Drug | rufinamide | 4.09e-05 | 29 | 153 | 4 | CID000129228 | |
| Drug | tazofelone | 4.49e-05 | 2 | 153 | 2 | CID000068745 | |
| Drug | 5-fluorowillardiine | 4.49e-05 | 2 | 153 | 2 | ctd:C095178 | |
| Drug | J-ST | 4.72e-05 | 11 | 153 | 3 | CID005288655 | |
| Drug | YM872 | 4.72e-05 | 11 | 153 | 3 | CID000148200 | |
| Drug | 0-ol | 4.72e-05 | 11 | 153 | 3 | CID000069892 | |
| Drug | sym 2206 | 4.72e-05 | 11 | 153 | 3 | CID005039877 | |
| Drug | AC1L1VI4 | 5.36e-05 | 31 | 153 | 4 | CID000010580 | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 5.58e-05 | 196 | 153 | 8 | 3375_UP | |
| Drug | willardine | 6.09e-05 | 32 | 153 | 4 | CID000005123 | |
| Drug | Atpa | 6.26e-05 | 12 | 153 | 3 | CID000002252 | |
| Drug | 1NaPP1 | 6.26e-05 | 12 | 153 | 3 | CID000004877 | |
| Drug | C-X6 | 6.26e-05 | 12 | 153 | 3 | CID005288002 | |
| Drug | Naspm | 8.10e-05 | 13 | 153 | 3 | CID000129695 | |
| Drug | Aldrin | 8.17e-05 | 207 | 153 | 8 | ctd:D000452 | |
| Drug | 2,4-Dichlorophenoxyacetic Acid | 8.63e-05 | 107 | 153 | 6 | ctd:D015084 | |
| Drug | Vitamin K 3 | EPHX1 FLNB CENPF PDZK1 GART E2F1 TWF2 AKIP1 ME1 GDI1 GDI2 PGAP6 PPIF WDR3 LIF SHANK2 SC5D KCTD10 NUMB FHL2 PCBP1 | 9.71e-05 | 1249 | 153 | 21 | ctd:D024483 |
| Drug | acetal | 1.03e-04 | 14 | 153 | 3 | CID000007765 | |
| Drug | quinoxaline-2,3-dione | 1.03e-04 | 14 | 153 | 3 | CID011469229 | |
| Drug | methyl 9-octadecenoate | 1.11e-04 | 112 | 153 | 6 | CID000008202 | |
| Drug | 11-ketotestosterone | 1.21e-04 | 38 | 153 | 4 | CID000104796 | |
| Drug | thiokynurenic acid | 1.28e-04 | 15 | 153 | 3 | CID003035667 | |
| Drug | 5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid | 1.33e-04 | 73 | 153 | 5 | CID011963505 | |
| Drug | Barbiturates | 1.34e-04 | 3 | 153 | 2 | ctd:D001463 | |
| Drug | 17-hydroxypregnenolone sulfate | 1.34e-04 | 3 | 153 | 2 | CID000152971 | |
| Drug | AR-2 | 1.34e-04 | 3 | 153 | 2 | CID000023840 | |
| Drug | HA-966 | 1.34e-04 | 39 | 153 | 4 | CID000001232 | |
| Drug | Indoles | 1.34e-04 | 39 | 153 | 4 | ctd:D007211 | |
| Drug | ochratoxin A | MRC1 AIMP1 CYP3A4 ANXA1 ZBTB4 GRIA1 UNC13D EYA3 ACSS2 TRIM24 ME1 AR SC5D TJP1 IHH CDH1 ARAP2 | 1.40e-04 | 911 | 153 | 17 | ctd:C025589 |
| Drug | AC1L1E5T | 1.42e-04 | 74 | 153 | 5 | CID000002653 | |
| Drug | 3',4'-dimethoxyflavone | 1.56e-04 | 16 | 153 | 3 | ctd:C509288 | |
| Drug | LY233536 | 1.56e-04 | 16 | 153 | 3 | CID000126239 | |
| Disease | Malignant neoplasm of breast | FLNA FLNB COL11A1 CENPF CYP3A4 DYNC2H1 PDZK1 E2F1 ZNF318 TEK DYSF ADAM10 AR NCOR1 SBNO1 ELAPOR1 FHL2 CDH1 PLOD1 | 2.65e-06 | 1074 | 151 | 19 | C0006142 |
| Disease | Disproportionate short stature | 2.86e-06 | 77 | 151 | 6 | C0878659 | |
| Disease | SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME | 2.60e-05 | 2 | 151 | 2 | C1848934 | |
| Disease | spondylocarpotarsal synostosis syndrome (implicated_via_orthology) | 2.60e-05 | 2 | 151 | 2 | DOID:0090116 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.79e-05 | 12 | 151 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 4.36e-05 | 321 | 151 | 9 | EFO_0004612, EFO_0004639 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 5.80e-05 | 80 | 151 | 5 | DOID:1459 (biomarker_via_orthology) | |
| Disease | central nervous system disease (implicated_via_orthology) | 7.01e-05 | 16 | 151 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 7.78e-05 | 3 | 151 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 7.78e-05 | 3 | 151 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | FLNA CENPF CYP3A4 DYNC2H1 PDZK1 E2F1 ADAM10 AR NCOR1 FHL2 CDH1 | 8.72e-05 | 525 | 151 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | FLNA CENPF CYP3A4 DYNC2H1 PDZK1 E2F1 ADAM10 AR NCOR1 FHL2 CDH1 | 8.72e-05 | 525 | 151 | 11 | C1257931 |
| Disease | Mammary Neoplasms | FLNA CENPF CYP3A4 DYNC2H1 PDZK1 E2F1 ADAM10 AR NCOR1 FHL2 CDH1 | 9.02e-05 | 527 | 151 | 11 | C1458155 |
| Disease | pulse pressure measurement | FLNB MYH6 CDSN COL11A1 MAP1B WDR7 DYNC2H1 TRPS1 LCA5L UNC13D FRYL ZNF318 TEC DYSF KCNH4 SPTBN4 WASF2 FHL2 TEC | 9.49e-05 | 1392 | 151 | 19 | EFO_0005763 |
| Disease | myopathy (implicated_via_orthology) | 1.08e-04 | 48 | 151 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.08e-04 | 447 | 151 | 10 | C3714756 | |
| Disease | Breast Carcinoma | FLNA CENPF CYP3A4 DYNC2H1 PDZK1 E2F1 ADAM10 AR NCOR1 FHL2 CDH1 | 1.08e-04 | 538 | 151 | 11 | C0678222 |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.20e-04 | 19 | 151 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | tacrolimus measurement | 1.55e-04 | 4 | 151 | 2 | EFO_0008458 | |
| Disease | estrone conjugate measurement | 1.55e-04 | 4 | 151 | 2 | EFO_0007971 | |
| Disease | tyrosine-protein kinase TEC measurement | 1.55e-04 | 4 | 151 | 2 | EFO_0020830 | |
| Disease | Schizophrenia | CHL1 PI4K2B CYP3A4 PDZK1 GRIA1 GRIA3 GRIA4 CMYA5 FBXL21P OPA1 SYNGAP1 NRXN3 SBNO1 CSMD1 | 1.86e-04 | 883 | 151 | 14 | C0036341 |
| Disease | tauro-beta-muricholate measurement | 2.58e-04 | 5 | 151 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 2.58e-04 | 5 | 151 | 2 | EFO_0800569 | |
| Disease | estradiol measurement | 2.61e-04 | 110 | 151 | 5 | EFO_0004697 | |
| Disease | Limb-girdle muscular dystrophy | 3.13e-04 | 26 | 151 | 3 | cv:C0686353 | |
| Disease | Prostatic Neoplasms | EPHX1 GALNT3 CENPF CYP3A4 ANXA1 PDZK1 UNC13D AR NCOR1 RPRD2 CDH1 | 3.46e-04 | 616 | 151 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | EPHX1 GALNT3 CENPF CYP3A4 ANXA1 PDZK1 UNC13D AR NCOR1 RPRD2 CDH1 | 3.46e-04 | 616 | 151 | 11 | C0376358 |
| Disease | contactin-1 measurement | 3.85e-04 | 6 | 151 | 2 | EFO_0020286 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 3.85e-04 | 6 | 151 | 2 | EFO_0021119 | |
| Disease | Psychosexual Disorders | 3.85e-04 | 6 | 151 | 2 | C0033953 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 3.85e-04 | 6 | 151 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | Hypoactive Sexual Desire Disorder | 3.85e-04 | 6 | 151 | 2 | C0020594 | |
| Disease | Sexual Arousal Disorder | 3.85e-04 | 6 | 151 | 2 | C0036902 | |
| Disease | Frigidity | 3.85e-04 | 6 | 151 | 2 | C0016722 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 3.85e-04 | 6 | 151 | 2 | EFO_0800294 | |
| Disease | Orgasmic Disorder | 3.85e-04 | 6 | 151 | 2 | C0029261 | |
| Disease | X-24574 measurement | 5.37e-04 | 7 | 151 | 2 | EFO_0800897 | |
| Disease | Periventricular Nodular Heterotopia | 5.37e-04 | 7 | 151 | 2 | C1868720 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 5.46e-04 | 274 | 151 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | eating disorder | 5.84e-04 | 32 | 151 | 3 | EFO_0005203 | |
| Disease | Liver Cirrhosis, Experimental | FLNA TCF20 ANXA1 ZBTB4 GBP2 RDH13 DYSF TRIM24 C1QC ADGRE1 FHL2 VAV1 | 6.59e-04 | 774 | 151 | 12 | C0023893 |
| Disease | Profound Mental Retardation | 7.62e-04 | 139 | 151 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 7.62e-04 | 139 | 151 | 5 | C0025363 | |
| Disease | Mental deficiency | 7.62e-04 | 139 | 151 | 5 | C0917816 | |
| Disease | clostridium difficile infection | 8.93e-04 | 144 | 151 | 5 | EFO_0009130 | |
| Disease | parasitemia measurement | 8.98e-04 | 37 | 151 | 3 | EFO_0005528 | |
| Disease | Prostatic Cancer, Castration-Resistant | 9.15e-04 | 9 | 151 | 2 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 9.15e-04 | 9 | 151 | 2 | C3658267 | |
| Disease | response to lamotrigine | 9.15e-04 | 9 | 151 | 2 | EFO_0007661 | |
| Disease | 2-hydroxystearate measurement | 9.15e-04 | 9 | 151 | 2 | EFO_0021059 | |
| Disease | Malignant tumor of prostate | 9.15e-04 | 9 | 151 | 2 | cv:C0376358 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 9.15e-04 | 9 | 151 | 2 | EFO_0800278 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 9.21e-04 | 145 | 151 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | serum albumin measurement | 9.82e-04 | 592 | 151 | 10 | EFO_0004535 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.06e-03 | 307 | 151 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.14e-03 | 152 | 151 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | postburn hypertrophic scarring severity measurement | 1.14e-03 | 10 | 151 | 2 | EFO_0007747 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.14e-03 | 10 | 151 | 2 | GO_0097327, GO_0097328 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.14e-03 | 10 | 151 | 2 | EFO_0022090 | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 1.14e-03 | 10 | 151 | 2 | EFO_0800289 | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.17e-03 | 312 | 151 | 7 | EFO_0004612, EFO_0010351 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.23e-03 | 315 | 151 | 7 | EFO_0004574, EFO_0004612 | |
| Disease | Liver carcinoma | 1.25e-03 | 507 | 151 | 9 | C2239176 | |
| Disease | APOE carrier status, cerebral amyloid angiopathy | 1.30e-03 | 42 | 151 | 3 | EFO_0006790, EFO_0007659 | |
| Disease | Prostatic Intraepithelial Neoplasias | 1.39e-03 | 11 | 151 | 2 | C0282612 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.39e-03 | 11 | 151 | 2 | EFO_0801531 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 1.39e-03 | 11 | 151 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 1.39e-03 | 11 | 151 | 2 | EFO_0800295 | |
| Disease | ficolin-3 measurement | 1.66e-03 | 12 | 151 | 2 | EFO_0020392 | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.66e-03 | 12 | 151 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.66e-03 | 12 | 151 | 2 | EFO_0800291 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.68e-03 | 166 | 151 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | high density lipoprotein particle size measurement | 1.86e-03 | 170 | 151 | 5 | EFO_0008592 | |
| Disease | cataract (biomarker_via_orthology) | 1.96e-03 | 13 | 151 | 2 | DOID:83 (biomarker_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.96e-03 | 13 | 151 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.96e-03 | 13 | 151 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 1.96e-03 | 13 | 151 | 2 | EFO_0800284 | |
| Disease | bilirubin measurement | 2.05e-03 | 442 | 151 | 8 | EFO_0004570 | |
| Disease | gamma-glutamylglutamate measurement | 2.27e-03 | 14 | 151 | 2 | EFO_0021137 | |
| Disease | X-21470 measurement | 2.27e-03 | 14 | 151 | 2 | EFO_0800817 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 2.27e-03 | 14 | 151 | 2 | cv:C2931907 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 2.27e-03 | 14 | 151 | 2 | EFO_0800283 | |
| Disease | Autistic Disorder | 2.32e-03 | 261 | 151 | 6 | C0004352 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.44e-03 | 670 | 151 | 10 | EFO_0006335, EFO_0006336 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.55e-03 | 53 | 151 | 3 | C4707243 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 2.61e-03 | 15 | 151 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.61e-03 | 15 | 151 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 2.61e-03 | 15 | 151 | 2 | EFO_0800301 | |
| Disease | serum gamma-glutamyl transferase measurement | GALNT3 OAS1 PGAP6 PPIF LRGUK SBNO1 TJP1 TXNL4B RP1 CSMD1 KDF1 ARAP2 | 2.67e-03 | 914 | 151 | 12 | EFO_0004532 |
| Disease | Mouth Neoplasms | 2.69e-03 | 54 | 151 | 3 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 2.69e-03 | 54 | 151 | 3 | C0153381 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYGAAVKTGKVKPGS | 191 | P40394 | |
| GLYEKVTGSGGPFKS | 291 | Q9H0X4 | |
| GTSPSSKYVKLNVGG | 26 | Q9H3F6 | |
| PAEGRLSGKSFTYKS | 3161 | Q96PZ7 | |
| PSGSSGGICEKSKLY | 336 | O14672 | |
| GASAGTIFVYGKDIK | 1396 | Q86UK0 | |
| ATYKGVPFEVKGKGV | 286 | Q12904 | |
| GKVYFTSDAGIAGKV | 4276 | Q6V0I7 | |
| KKTSLGPGGSYQISE | 141 | Q9NQ31 | |
| KECFGGIVGAKSPYV | 1061 | Q5VU97 | |
| EIPGSTKGVSGSYFR | 291 | Q8WZ64 | |
| LFILYTSGSTGKPKG | 311 | Q9NR19 | |
| VGYFTKENPVKGSPG | 321 | Q15517 | |
| GYKAKTIVTALPGSF | 446 | Q14156 | |
| TSDKPLQGDGYSGAK | 1071 | P49792 | |
| PGGGDGAEYKTLKIS | 161 | Q96T37 | |
| FRKDGVPIGYKGSTF | 51 | O43447 | |
| AQKYGKDPTVVIGSG | 326 | Q99504 | |
| DLSGYKGSSTPTKGI | 356 | O60271 | |
| EGGSYGFSLKTVQGK | 141 | Q5T2W1 | |
| YVQTVKSSKGGPGSA | 21 | P04083 | |
| PNGKSKGFGFVSYEK | 226 | Q13310 | |
| GVKDSPGVYTKVSAF | 851 | P56730 | |
| GFAGIDSSSPEVKGY | 256 | Q15365 | |
| EGSFVYKGGKIYKVP | 106 | P50395 | |
| ISVGFIGYPNVGKSS | 311 | Q13823 | |
| YKITKGRAIFASGSP | 421 | P48163 | |
| LEKDSGGKTPGDFSY | 1856 | P46821 | |
| KDKYVGVSSDSVGGF | 156 | Q14677 | |
| FIGAYAGSKEKGSVE | 1181 | O00533 | |
| KSKTDGGTTDYAAPV | 71 | A0A0B4J1V0 | |
| GGTTDYAAPVKGRFT | 76 | A0A0B4J1V0 | |
| GGTKAPKPSFVSYVR | 11 | Q9C0I1 | |
| VTYGPDTSGKDVFQK | 166 | P15018 | |
| TLAGGPSFTSKGLKY | 681 | Q6UXG2 | |
| TGKPVTLKDVFGAYS | 166 | P08684 | |
| FTSGGETCIYPDKKS | 1641 | P12107 | |
| SKGYGVATPKGSALR | 761 | P42263 | |
| SKGYGVATPKGSSLR | 751 | P48058 | |
| THFTVYTKGAGKAPL | 866 | O75369 | |
| GISGKTLKPGSYVSE | 6181 | Q7Z5P9 | |
| KKTVGEAPDGPASAY | 386 | Q13608 | |
| TVKGVNFYGPKSEFV | 436 | Q5TAQ9 | |
| YGGDTGSPEISFTKI | 2266 | O94915 | |
| STSIFEGGYKAHAPK | 1441 | Q9Y4C0 | |
| VGPTGTGKSVYVKDK | 1891 | Q6ZR08 | |
| KPSVPEYKVASVGGS | 201 | Q9UQ05 | |
| GVDDTLGKGTAPYTK | 501 | O95447 | |
| KQGTFSKPGGYRLFT | 421 | P32456 | |
| FGPYPEKSGKDSLVS | 726 | Q96M69 | |
| TAEYSPFKGGYTKGL | 306 | P10275 | |
| PASAGYSGKSEVGLV | 31 | Q9HCN3 | |
| YPVCVSKVVKGGSSG | 51 | P00973 | |
| TGSIPIYSFHGKVEK | 151 | Q9Y2T6 | |
| PGVPASSKSGKAFSY | 341 | Q969F2 | |
| LKDYVTGGACPSKAT | 21 | Q8NBN7 | |
| KYPVVSDGKRFLGSG | 141 | Q02809 | |
| ISQGSSGSYFVKDPK | 126 | Q8TCG2 | |
| GSAVGGGYTAKKTFD | 106 | O60313 | |
| KAKDTQGFYGTVSSP | 1201 | Q460N5 | |
| YDTSTGKFTCKVPGL | 151 | P02747 | |
| NPYGPAGTGKTESVK | 1686 | Q8NCM8 | |
| GPEHEGKYTFRAKGT | 576 | Q8N9C0 | |
| PGYGFSEASSKKGFN | 186 | P07099 | |
| GKGVKSPGEKSRYET | 116 | Q01094 | |
| KKGFADIPTGKTSPY | 2986 | P49454 | |
| LGTTKAAGYKVSPGR | 126 | Q7Z6I8 | |
| AYGGKYSVKTPAKGG | 441 | Q6E0U4 | |
| ADFKVYTKGAGSGEL | 501 | P21333 | |
| TEGYDLKGFKGDTPV | 16 | Q5T0N1 | |
| KFGGYKLLVTPTSGG | 56 | Q05707 | |
| KDETYPIKTPTFAGG | 351 | Q14435 | |
| RPVTGGHLGKKESSY | 521 | Q5JV73 | |
| FYPDGGDQETAKTGK | 321 | Q9NYF8 | |
| YAKGEDFTVTSKPAG | 2921 | Q8N3K9 | |
| AEYKASGGPSVFQKP | 646 | Q8TDC3 | |
| NPISGLGGTKYISFE | 226 | Q14192 | |
| KGEAIGFYSVKPTGS | 151 | Q9Y6X4 | |
| EGSFVYKGGKIYKVP | 106 | P31150 | |
| DSKTPGRGGAKETYG | 491 | Q32P44 | |
| TGKPVTLKHVFGAYS | 166 | P24462 | |
| LDSKGYGIATPKGSA | 741 | P42261 | |
| TPFGLIKGHAYSVTG | 246 | O14815 | |
| TKGVYVPFGGKSMIT | 2466 | Q9P225 | |
| SGGLTGFKTAPYKER | 1156 | Q5VT52 | |
| VKKFLTPGYSTSGHV | 1161 | A3KN83 | |
| HSVAYKPGGFKASTG | 216 | P56856 | |
| TTGLTYPKFSDVTGK | 896 | O75923 | |
| GKVFYSITGQGADTP | 186 | P12830 | |
| VPEKTLGASGRYEGK | 56 | Q14623 | |
| PKIYTKTGDKGFSST | 56 | Q96EY8 | |
| YGKADIIKPSFFPGS | 1636 | P56715 | |
| GVRTGKCSFPVKYLG | 31 | P49757 | |
| PATIQTDGFVKYGKS | 1091 | P22897 | |
| SGAAKQPKVGFYSSL | 16 | Q9UKT6 | |
| GLGFKTPKEAIEGTY | 41 | P62280 | |
| FGKPGVGKTTLARYI | 36 | Q5TCS8 | |
| GFPYASSGENTGIVK | 251 | Q68CR1 | |
| TLARDPTTGKHKGYG | 256 | Q9UHX1 | |
| SVKGKNAPTTAGFSY | 346 | P42680 | |
| KSSAGVPEKTGYPDS | 31 | Q8NE18 | |
| VPTSDGKYKAFSTCG | 246 | Q6IFN5 | |
| YSGPKLEDGKVTISF | 176 | P53041 | |
| SSVVYSEAGKDKGPP | 1896 | O75376 | |
| FKPRVGSHVGTGYKS | 41 | Q7Z5V6 | |
| SKSGYPKTPGRAGTE | 411 | P13521 | |
| FRTSGEKPIYSVGGI | 26 | Q96GC5 | |
| GFTPEEKSGLYKLTG | 341 | P11055 | |
| KDGLYKIGSGYSGTV | 381 | O75592 | |
| KGFGYKGSTFHRVIP | 86 | P30405 | |
| SIAGGKGSTPYKGDD | 741 | Q14160 | |
| KGSTPYKGDDEGIFI | 746 | Q14160 | |
| GSSFSYPDVKLKGIP | 156 | Q8NAX2 | |
| GFTSEEKAGVYKLTG | 341 | P13533 | |
| GRKEGVYIKVGSASP | 191 | Q16586 | |
| TKSGLTGYIKGIFGF | 611 | Q9UHB9 | |
| LEYGTKLVGGTTPGK | 76 | P53597 | |
| KPEGAAKTIGSYVPG | 456 | Q9UPX8 | |
| TGEKKDGFSDPIIYT | 521 | Q14246 | |
| YPAATTAKQGKTGAE | 166 | Q6UXG3 | |
| VAISKGKSPDYANGG | 56 | Q8NCQ2 | |
| PGTGKSYLAKAVATE | 176 | O75351 | |
| SEKAGFNYESPSKGG | 81 | Q9UHF7 | |
| PTITSAAGYDGKAFG | 591 | O15164 | |
| KAFNSSGVGPYSKTV | 586 | Q6ZTA4 | |
| HPYSKVFGTTAGGKG | 371 | Q92574 | |
| KSSFKPYSKGSGGGD | 151 | Q9H7S9 | |
| TGKKPNSTGEYGKGF | 311 | Q9UK11 | |
| PVGGCGKKFTTVYNL | 241 | Q2QGD7 | |
| GYSKSEDLSSGVPKP | 981 | Q96PV0 | |
| VKDITGFEGKISSPY | 371 | Q7RTY8 | |
| YAGSGTKNGSLDPAK | 951 | P38935 | |
| PVGSGLGYIAGSKVK | 196 | Q9H2V7 | |
| PAVGSTKYFGTAKAR | 776 | P15498 | |
| YDKSPGGNGFAKVSS | 1666 | Q92545 | |
| GKQKGIVAAFYSGPS | 541 | P80108 | |
| AYSKGSAGTRPGDVK | 801 | Q9P1Z0 | |
| FYKDSKGPASGSTHG | 2456 | Q9H254 | |
| FTSKGPGPYADVVKS | 1131 | P08922 | |
| SVSSPGSVIYDGKGF | 1441 | Q86WI1 | |
| SSEPYFGDGPIKSKK | 466 | Q02763 | |
| SGTGFGDKFKPVIGT | 711 | P49790 | |
| TTYKGGASEKAGSSP | 546 | Q9UGU0 | |
| IYTGKEGKSSRGCPI | 876 | O43151 | |
| SKGYPGDYTKGVEIT | 341 | P22102 | |
| IPFSGKGYVLGETSN | 251 | Q9H040 | |
| EFVESKEKLGTSGYP | 211 | Q9Y6W5 | |
| SSYSSKGKPPEADGV | 1396 | Q07157 | |
| TDGSSNGKAAYTGPK | 471 | Q9WJR5 | |
| KVDYGSPDHTKFVGS | 91 | Q9NX01 | |
| PGETQGDSYFTGKKT | 736 | Q9UNX4 | |
| NPSSFEGKGPLSYVK | 256 | O75845 | |
| GRKLPASEGVGKGTY | 866 | Q9Y4E6 | |
| IFYSSGGKGAPETKG | 1571 | Q5VUA4 | |
| KGILGKDVSGFSDPY | 121 | Q70J99 | |
| YAATRATVKKEFGGG | 101 | Q6IBS0 | |
| PGSVSVDKKGYIFLT | 681 | Q9BRZ2 | |
| LKVDGAYVAVKFPGT | 671 | O95071 |